Skeletal system disorder
MONDO:0005172A disease involving the skeletal system.
Also known as: disease of skeletal system, disease or disorder of skeletal system, disorder of skeletal system, skeletal system disease, skeletal system disease or disorder, disease of bone and/or joint, osteoarthropathy
9715 clinical trials for this condition and its sub-types, 4 tagged with Skeletal system disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skeletal system disorder
-
Bone disorder 53 trials · 6,290 incl. sub-types
27 sub-types
- Bone inflammation disease 1 trial · 2,667 incl. sub-types Sub-types →
- Bone neoplasm 26 trials · 2,116 incl. sub-types Sub-types →
- Skeletal dysplasia 1 trial · 660 incl. sub-types Sub-types →
- Bone development disease 2 trials · 527 incl. sub-types Sub-types →
- Disease of bone structure 1 trial · 456 incl. sub-types Sub-types →
- Bone remodeling disease 5 trials · 411 incl. sub-types Sub-types →
- Skull disorder 1 trial · 387 incl. sub-types Sub-types →
- Metabolic bone disorder 9 trials · 316 incl. sub-types Sub-types →
- Osteonecrosis 59 trials · 224 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 1 11 trials · 16 incl. sub-types Sub-types →
- Periostitis 0 trials · 16 incl. sub-types Sub-types →
- GM1 gangliosidosis 12 trials Sub-types →
- ACAN-related short stature spectrum 0 trials · 1 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 9 1 trial
- Baastrup syndrome 0 trials
- Duane anomaly-myopathy-scoliosis syndrome 0 trials
- SLC10A7-congenital disorder of glycosylation 0 trials
- Sagliker syndrome 0 trials
- Ainhum 0 trials
- Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome 0 trials
- Cervical rib disease 0 trials
- Coxoauricular syndrome 0 trials
- Metachondromatosis 0 trials
- Mixed sclerosing bone dystrophy with extra-skeletal manifestations 0 trials
- Mueller-weiss syndrome 0 trials
- Proteoglycan-related bone disorder 0 trials
-
Arthropathy 138 trials · 3,198 incl. sub-types
24 sub-types
- Arthritic joint disease 194 trials · 2,548 incl. sub-types Sub-types →
- Temporomandibular joint disorder 200 trials · 222 incl. sub-types Sub-types →
- Spondyloarthropathy 121 trials · 198 incl. sub-types Sub-types →
- Bursitis 111 trials · 119 incl. sub-types Sub-types →
- Vertebral joint disorder 0 trials · 117 incl. sub-types Sub-types →
- Frozen shoulder 101 trials
- Shoulder impingement syndrome 81 trials
- Patellofemoral pain syndrome 78 trials
- Articular cartilage disorder 26 trials · 34 incl. sub-types Sub-types →
- Ankylosis 19 trials · 23 incl. sub-types Sub-types →
- De Quervain disease 17 trials
- Synovium neoplasm 0 trials · 17 incl. sub-types Sub-types →
- Tenosynovitis 4 trials · 14 incl. sub-types Sub-types →
- Hypermobility syndrome 13 trials
- Hemarthrosis 7 trials
- Crystal arthropathy 3 trials
- Ganglion or cyst of synovium/tendon/bursa 3 trials
- Hydrarthrosis 2 trials · 3 incl. sub-types Sub-types →
- Neurogenic arthropathy 2 trials
- Synovial plica syndrome 1 trial
- Behcet syndrome arthropathy 0 trials
- Tietze syndrome 0 trials
- Secondary hypertrophic osteoarthropathy 0 trials
- Transient arthropathy 0 trials Sub-types →
-
Bone marrow disorder 18 trials · 1,761 incl. sub-types
7 sub-types
- Bone marrow neoplasm 3 trials · 1,631 incl. sub-types Sub-types →
- Polycythemia 9 trials · 99 incl. sub-types Sub-types →
- Bone marrow failure syndrome 48 trials Sub-types →
- Osteomyelitis 43 trials · 46 incl. sub-types Sub-types →
- Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
- Drachtman Weinblatt Sitarz syndrome 0 trials
- Premature ovarian failure 15 0 trials
-
Vertebral column disorder 82 trials · 1,241 incl. sub-types
15 sub-types
- Spinal cord injury 650 trials
- Intervertebral disk degenerative disorder 122 trials · 216 incl. sub-types Sub-types →
- Spinal stenosis 120 trials · 154 incl. sub-types Sub-types →
- Vertebral disorder 3 trials · 129 incl. sub-types Sub-types →
- Vertebral joint disorder 0 trials · 117 incl. sub-types Sub-types →
- Lumbar disk disease 82 trials
- Coccygodynia 19 trials
- Spondylocostal dysostosis 5 trials · 8 incl. sub-types Sub-types →
- Epidural spinal canal neoplasm 3 trials · 5 incl. sub-types Sub-types →
- Sacrum chordoma 4 trials
- Sacrococcygeal teratoma 2 trials
- Baastrup syndrome 0 trials
- Dropped head syndrome 0 trials
- Lumbosacral lipoma 0 trials
- Tuberculosis, spinal 0 trials
-
Periodontal disorder 302 trials · 978 incl. sub-types
4 sub-types
- Periodontitis 436 trials · 600 incl. sub-types Sub-types →
- Gingival disorder 26 trials · 337 incl. sub-types Sub-types →
- Papillon-Lefevre disease 5 trials
- Regional odontodysplasia 1 trial
-
Tooth disorder 37 trials · 890 incl. sub-types
11 sub-types
- Tooth hard tissue disease 1 trial · 526 incl. sub-types Sub-types →
- Dental pulp disorder 37 trials · 276 incl. sub-types Sub-types →
- Anodontia 59 trials Sub-types →
- Tooth agenesis 22 trials Sub-types →
- Dental abscess 15 trials
- Tooth erosion, non-bacterial 14 trials Sub-types →
- Dental fluorosis 11 trials
- Odontogenic neoplasm 0 trials · 5 incl. sub-types Sub-types →
- Dentinogenesis imperfecta 2 trials Sub-types →
- Taurodontism 1 trial
- Dental radicular dysplasia 0 trials
-
Flatfoot 60 trials
-
Patellar tendinitis 22 trials
-
Marfan syndrome 21 trials
1 sub-type
- Neonatal Marfan syndrome 0 trials
-
Fibrodysplasia ossificans progressiva 10 trials
-
Syndactyly 3 trials · 9 incl. sub-types
2 sub-types
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- Non-syndromic syndactyly 0 trials Sub-types →
-
Polydactyly 2 trials · 9 incl. sub-types
2 sub-types
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- Non-syndromic polydactyly 0 trials · 1 incl. sub-types Sub-types →
-
Skeletal ligament disorder 0 trials · 7 incl. sub-types
1 sub-type
- Achilles bursitis 7 trials
-
Chondroma 4 trials
3 sub-types
- Periosteal chondroma 0 trials
- Phalanx chondroma 0 trials
- Soft tissue chondroma 0 trials Sub-types →
-
Coffin-Siris syndrome 1 trial
11 sub-types
- Coffin-Siris syndrome 1 0 trials
- Coffin-Siris syndrome 10 0 trials
- Coffin-Siris syndrome 11 0 trials
- Coffin-Siris syndrome 12 0 trials
- Coffin-Siris syndrome 5 0 trials
- Coffin-Siris syndrome 7 0 trials
- Coffin-Siris syndrome 8 0 trials
- Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
-
Cartilage-hair hypoplasia 1 trial
1 sub-type
-
Cherubism 1 trial
1 sub-type
-
Ochronosis disorder 1 trial
1 sub-type
- Exogenous ochronosis 0 trials
-
Primary basilar invagination 1 trial
-
Symphalangism 0 trials · 1 incl. sub-types
6 sub-types
- Proximal symphalangism 1 trial Sub-types →
- NOG-related symphalangism spectrum disorder 0 trials Sub-types →
- Distal symphalangism 0 trials
- Symphalangism of toes 0 trials
- Symphalangism with multiple anomalies of hands and feet 0 trials
- Symphalangism, C. S. Lewis type 0 trials
-
Al-Gazali syndrome 0 trials
-
Buschke-Ollendorff syndrome 0 trials
-
Rienhoff syndrome 0 trials
-
Teebi-Shaltout syndrome 0 trials
-
Anterior cranial fossa meningioma 0 trials
3 sub-types
- Cerebral falx meningioma 0 trials
- Olfactory groove meningioma 0 trials
- Pituitary stalk meningioma 0 trials
-
Brachydactyly 0 trials
22 sub-types
- Ballard syndrome 0 trials
- Berk-Tabatznik syndrome 0 trials
- Cooks syndrome 0 trials
- Osebold-Remondini syndrome 0 trials
- Brachydactyly type A1 0 trials
- Brachydactyly type A1A 0 trials
- Brachydactyly type A1B 0 trials
- Brachydactyly type A1C 0 trials
- Brachydactyly type A1D 0 trials
- Brachydactyly type A2 0 trials
- Brachydactyly type A3 0 trials
- Brachydactyly type A4 0 trials
- Brachydactyly type A5 0 trials
- Brachydactyly type A7 0 trials
- Brachydactyly type B 0 trials Sub-types →
- Brachydactyly type C 0 trials
- Brachydactyly type D 0 trials
- Brachydactyly type E 0 trials Sub-types →
- Brachydactyly-arterial hypertension syndrome 0 trials
- Camptobrachydactyly 0 trials
- Non-syndromic brachydactyly 0 trials Sub-types →
- Preaxial digit brachydactyly-webbed fingers 0 trials
-
Brachydactyly-syndactyly syndrome 0 trials
-
Cartilage cancer 0 trials
-
Cartilage development disorder 0 trials
-
Cranial nodular fasciitis 0 trials
-
Laryngeal cartilage cancer 0 trials
-
Middle cranial fossa meningioma 0 trials
1 sub-type
- Internal auditory canal meningioma 0 trials
-
Necrosis of ear ossicle 0 trials
-
Posterior cranial fossa meningioma 0 trials
1 sub-type
- Clivus meningioma 0 trials Sub-types →
-
Skeletal tuberculosis 0 trials
1 sub-type
- Tuberculosis, spinal 0 trials
-
Sternal neoplasm 0 trials
2 sub-types
- Benign neoplasm of sternum 0 trials
- Sternum cancer 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 3331 trials in this tab.
-
Engineered t cells target FLT3 in Hard-to-Treat leukemia
Cure Recruiting nowResearchers are testing a new cell therapy called anti-FLT3 CAR-T (HG-CT-1) in adults and children with acute myeloid leukemia (AML) that has come back or stopped responding to standard treatment. The study is a Phase 1 dose-escalation trial, meaning its first goal is to find out…
Phase 1 • Sponsor: Hemogenyx Pharmaceuticals LLC • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Can adding venetoclax make donor stem cell transplants safer for High-Risk blood cancers?
Cure Recruiting nowResearchers test whether adding venetoclax to a standard conditioning regimen called FLAMSA-treosulfan is safe for people with high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or secondary acute myeloid leukemia who are receiving a donor blood stem cell trans…
Phase 1/2 • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Half-Matched stem cells tested as a cure for severe aplastic anemia
Cure Recruiting nowResearchers are testing a stem cell transplant from a half-matched family member in children and young adults with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. Participants receive chemotherapy and radiation to prepare their body, the…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a Four-Drug prep make curative transplant safer for older AML patients?
Cure Recruiting nowOlder adults with acute myeloid leukemia (AML) often fare poorly with chemotherapy alone, and a stem cell transplant can offer better long-term survival but carries a high risk of transplant-related death. Researchers are comparing two drug combinations given before a haploidenti…
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Half-Matched stem cells tested as cure for myelofibrosis
Cure Recruiting nowMyelofibrosis is a bone marrow disease that can lead to leukemia. A stem cell transplant from a matched donor can cure it, but many patients cannot find a match. This trial tests a new transplant protocol using half-matched family donors, with a special drug regimen before transp…
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Two-Drug combo targets leukemia that outsmarted its first treatment
Disease control Recruiting nowResearchers are testing whether adding an experimental drug called RVU120 to venetoclax can help adults with acute myeloid leukemia (AML) that has come back or stopped responding to earlier venetoclax-based treatment. The trial enrolls about 98 adults who have already failed a hy…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill combo aims to tackle tough leukemia
Disease control Recruiting nowThis early-stage trial tests two oral drugs, ziftomenib and quizartinib, together in adults with relapsed or hard-to-treat acute myeloid leukemia (AML) that has certain genetic markers. The goal is to find a safe and effective all-pill treatment for common AML subtypes. About 44 …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to tame back inflammation in axial spondyloarthritis
Disease control Recruiting nowThis study tests an experimental oral drug called GRWD0715 for axial spondyloarthritis, a chronic inflammatory condition affecting the spine and pelvis. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduces inflammation and im…
Phase 1/2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to wipe out stubborn leukemia traces
Disease control Recruiting nowThis study tests whether two drugs, venetoclax and revumenib, can control minimal residual disease (MRD) in people with acute myeloid leukemia (AML). MRD means small numbers of cancer cells remain after initial treatment, raising the risk of relapse. The trial enrolls about 8 par…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThis study tests whether an investigational drug called PLG0206 can prevent infections from coming back after knee replacement surgery. About 240 adults who need a special cleaning surgery (DAIR) for an infected knee joint will receive either PLG0206 or a placebo during the proce…
Phase 2/3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Injectable hydrogel could ease back pain without surgery
Disease control Recruiting nowThis study tests a hydrogel implant injected into damaged spinal discs to treat degenerative disc disease. About 225 adults with chronic low back pain will receive either the implant or standard care like physical therapy. The goal is to see if the implant safely improves pain an…
Sponsor: ReGelTec, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims for deeper remission in older leukemia patients
Disease control Recruiting nowThis phase II trial tests whether adding gilteritinib to the usual two-drug therapy (azacitidine and venetoclax) can help older or frail adults with a specific type of acute myeloid leukemia (FLT3-mutated) achieve deeper remission. About 147 participants will be randomly assigned…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo shows promise in AML fight
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy can better treat acute myeloid leukemia (AML) that is newly diagnosed or has come back. About 116 adults with AML or high-risk MDS will receive the combination. The goal is to see if the combo improves r…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Immune-Targeting drug surovatamig enters first human tests for arthritis and lupus
Disease control Recruiting nowThis Phase 1 trial tests surovatamig, a bispecific T-cell engager, in 48 adults with rheumatoid arthritis or systemic lupus erythematosus. The study gives the drug as injections in increasing doses to check safety, side effects, and how the body processes it. It is too early to k…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill could transform leukemia treatment, phase 3 trial begins
Disease control Recruiting nowThis study tests a new oral drug, QTX-2101, combined with standard ATRA therapy for adults newly diagnosed with a low-risk form of acute promyelocytic leukemia (APL). The goal is to see if the oral capsule works as well as the current intravenous treatment. About 150 participants…
Phase 3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a targeted drug boost chemo success in leukemia?
Disease control Recruiting nowThis phase II trial is testing whether adding the drug venetoclax to standard chemotherapy can improve remission rates in younger patients with intermediate-risk acute myeloid leukemia (AML). About 153 participants will receive either standard chemo or a combination with venetocl…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Boosting transplants with donor immune cells to fight blood cancer relapse
Disease control Recruiting nowThis study tests whether giving donor white blood cells (lymphocytes) soon after a stem cell transplant can lower the chance of cancer returning in people with high-risk blood cancers like leukemia or lymphoma. Participants receive chemotherapy, a stem cell transplant, and then a…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for leukemia patients: olverembatinib trial launches
Disease control Recruiting nowThis phase 2 trial tests whether the drug olverembatinib can safely control chronic myeloid leukemia (CML) in people who are newly diagnosed. About 50 adults will take the drug by mouth. Researchers will track side effects and how well the drug works. The study is currently recru…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail of 5 drugs targets tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tackle rare nasal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can shrink advanced squamous cell cancers of the nasal cavity and sinuses better than chemotherapy alone. About 35 adults with newly diagnosed, untreated stage II to IVb disease …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: first human trial of PRT12396 begins
Disease control Recruiting nowThis early-stage study tests a new drug, PRT12396, in about 100 people with polycythemia vera or myelofibrosis—rare blood cancers. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug controls the disease, but this …
Phase 1 • Sponsor: Prelude Therapeutics Incorporated • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost remission in IDH2-Mutated AML
Disease control Recruiting nowThis phase II trial tests whether adding enasidenib to standard ASTX727 and venetoclax improves remission rates in older adults (or younger unfit patients) with newly diagnosed IDH2-mutated acute myeloid leukemia (AML). About 93 participants will be randomly assigned to receive e…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a Rose-Scented oil replace standard fillings in Kids' cavities?
Disease control Recruiting nowThis study looks at whether an essential oil from Pelargonium graveolens (a type of geranium) can be used to treat deep cavities in children's baby teeth. The goal is to see if it works as well as current materials to relieve pain and prevent infection. Thirty children will recei…
Sponsor: Tanta University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowThis study tests an oral drug called pacritinib in people aged 12 and older with myelodysplastic syndromes (MDS) or related blood cancers (MDS/MPN). The goal is to find the best dose and see if it can shrink or control the disease. Participants take capsules twice daily for up to…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a cementless hip stem hold up in asian patients?
Disease control Recruiting nowResearchers at a Korean hospital are following 210 adults who receive a cementless total hip replacement using the collarless Actis femoral stem. The study focuses on Asian patients, who tend to be younger at surgery and more often need the operation because of lost blood supply …
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could detoxing metals boost chemo for leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether two drugs that lower metal levels in the body can help people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) respond better to chemotherapy. The study will enroll 58 adults and aims to find the safest dose and check f…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug afimkibart tested for Long-Term arthritis control
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of a drug called afimkibart in people with moderate to severe rheumatoid arthritis. Participants have already taken afimkibart in a previous study and will continue taking it. The goal is to see if the drug remains safe…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Tough-to-Treat leukemia: multiple drug cocktails tested
Disease control Recruiting nowThis phase II trial tests several experimental drug combinations against the standard treatment for high-risk acute myeloid leukemia (AML) in patients aged 59 or younger. The goal is to see if newer regimens, including venetoclax and liposome formulations, can better shrink cance…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo pill aims to shrink spleens and ease symptoms in bone marrow cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding pelabresib to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. About 460 adults who have not taken JAK inhibitors before will receive either the combination or a …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowThis study tests whether adding a patient's own concentrated bone marrow cells to a standard hip surgery (core decompression) can prevent the hip ball from collapsing and delay or avoid the need for a hip replacement. It includes 192 adults with early-stage osteonecrosis (before …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Recruiting nowThis trial tests an experimental drug called DDY391 in about 220 adults with moderate to severe psoriatic arthritis, a condition that causes joint pain, swelling, and skin patches. Researchers want to see whether DDY391 can reduce joint symptoms better than a placebo and at what …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a tailored diet boost brain and body health in denture-wearers?
Disease control Recruiting nowThis study tests a 6-month nutritional program for adults aged 60–80 who wear complete dentures. Participants receive personalized dietary advice, meal plans, cooking workshops, and a mobile app. The goal is to see if the program improves diet quality, chewing ability, muscle str…
Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered t cells target hidden leukemia cells in new trial
Disease control Recruiting nowThis phase I trial tests a new treatment for adults with acute myeloid leukemia (AML) who have minimal residual disease (MRD) — small amounts of cancer cells that remain after standard therapy. The treatment uses the patient's own T cells, genetically modified to recognize a prot…
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowThis Phase 3 study tests whether the oral drug zasocitinib (TAK-279) can improve symptoms of active psoriatic arthritis in people who have never used biologic treatments. About 1,088 adults will receive either zasocitinib, an active comparator, or a placebo for up to 60 weeks. Th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody tested to tame childhood arthritis and cut steroid use
Disease control Recruiting nowResearchers are testing an experimental drug called GenaKumab in children and teens with active systemic juvenile idiopathic arthritis, a condition that causes joint inflammation and recurring fevers. The trial enrolls about 290 participants aged 2 to under 18 who have had sympto…
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new anesthetic give surgeons a clearer view during sinus surgery?
Disease control Recruiting nowThis trial tests whether fospropofol disodium, a newer form of propofol, can improve the surgical field quality during endoscopic sinus surgery compared to standard propofol anesthesia. The study includes adults aged 18-65 with chronic rhinosinusitis who are scheduled for sinus s…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
3D printed dentures face off against traditional milled ones in new trial
Disease control Recruiting nowThis study compares two types of full dentures: 3D printed ones and milled ones. Researchers want to see which lasts longer and causes fewer problems over five years. Sixty-eight adults who need complete dentures will take part, and the main focus is how many dentures are still w…
Sponsor: Dentsply Sirona Implants and Consumables • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a new drug combo beat standard chemo for kids with AML?
Disease control Recruiting nowThis large phase 3 trial is testing whether a new formulation of two chemotherapy drugs (CPX-351) and a targeted drug called gilteritinib can improve outcomes for children and young adults with newly diagnosed acute myeloid leukemia (AML). The study compares these new approaches …
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Which drug first? trial tests sequence of carboplatin and olaparib in aggressive prostate cancer
Disease control Recruiting nowResearchers are comparing two sequences of treatment for metastatic castration-resistant prostate cancer that carries certain DNA repair gene mutations. Participants receive either carboplatin first and olaparib second, or olaparib first and carboplatin second, switching after th…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for kids with leukemia: new drug combo aims to boost remission
Disease control Recruiting nowThis phase 2 trial tests whether adding the targeted drug venetoclax to standard chemotherapy is safe and effective for children and young adults (up to age 22) with newly diagnosed acute myeloid leukemia (AML). The study aims to see if this combination can reduce the amount of c…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo attack on stubborn leukemia: chemo then transplant
Disease control Recruiting nowThis early-phase trial tests a two-step approach for people with acute myeloid leukemia or related blood cancers that have returned or not responded to treatment. First, patients receive intensive chemotherapy (CLAG-M or FLAG-Ida) followed immediately by a reduced-intensity stem …
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New triple therapy aims to boost survival in frail AML patients
Disease control Recruiting nowThis phase 3 trial will test whether adding the drug quizartinib to the standard two-drug combination (venetoclax and azacitidine) helps adults with newly diagnosed acute myeloid leukemia (AML) live longer. The study includes 376 people aged 18 and older who cannot receive intens…
Phase 3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Stem cell gel could offer new hope for knee arthritis sufferers
Disease control Recruiting nowThis Phase 3 trial tests whether a gel made from donated umbilical cord stem cells (CARTISTEM) can reduce pain and improve knee function better than a simple surgical cleanup (debridement) in people with knee cartilage damage and osteoarthritis. About 300 adults aged 18-75 with m…
Phase 3 • Sponsor: Medipost, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental pill targets resistant disease
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, AJ1-11095, in about 76 adults with myelofibrosis (a type of bone marrow cancer) whose disease has stopped responding to standard JAK2 inhibitor therapy. The main goals are to check the drug's safety, find the best dose, and …
Phase 1 • Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could everyday heart drugs shield cancer patients from Radiation's cardiac toll?
Disease control Recruiting nowThis study tests whether two common heart medications—atorvastatin (a statin) and lisinopril (an ACE inhibitor)—can prevent or reduce heart damage caused by radiation therapy for chest cancers like breast, lung, and esophageal cancer. About 60 adults receiving chest radiation wil…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New spinal device aims to improve back surgery outcomes
Disease control Recruiting nowThis study tests a new device called CORUS-LX for spinal fusion surgery in people with degenerative disc disease in the lower back. About 250 adults will either get the new device or standard surgery. The goal is to see if the device helps bones fuse better and reduces the need f…
Sponsor: Providence Medical Technology, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo aims to shrink spleen and boost transplant success in myelofibrosis
Disease control Recruiting nowThis study tests whether giving high-dose ruxolitinib and busulfan before a stem cell transplant can reduce spleen size and help the transplant work better in people with myelofibrosis. About 30 adults aged 18 to 75 with an enlarged spleen and a matched donor will take part. The …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for AML patients: quizartinib maintenance trial launches
Disease control Recruiting nowThis study tests two different doses of the drug quizartinib as a maintenance therapy for adults with a specific type of acute myeloid leukemia (FLT3-ITD positive) who are in their first complete remission after initial treatment and have not had a stem cell transplant. The goal …
Phase 2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a heart drug tame rheumatoid arthritis?
Disease control Recruiting nowThis trial tests whether nicorandil, a drug currently used for heart conditions, can reduce disease activity and symptoms in people with rheumatoid arthritis. About 70 adults with moderate-to-severe RA will take either nicorandil or a placebo twice daily for three months, while c…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for tough leukemias: experimental pill targets genetic weakness
Disease control Recruiting nowThis study tests an oral drug called revumenib in people with certain types of leukemia that have relapsed or not responded to standard therapy. The trial has two parts: first, finding the best dose, then testing that dose in four groups based on leukemia type. About 447 particip…
Phase 1/2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill hopes to tame rare childhood brain diseases
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called nizubaglustat (AZ-3102) in people aged 4 and older with Niemann-Pick type C disease, GM1 gangliosidosis, or GM2 gangliosidosis. The study lasts 18 months and compares the drug to a placebo to see if it is safe and can slow disease prog…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for leukemia patients who failed standard treatments
Disease control Recruiting nowThis study tests a drug called ponatinib in 50 adults with chronic myeloid leukemia (CML) whose cancer did not respond to or they could not tolerate other targeted therapies. The goal is to see if ponatinib can control the disease by blocking a protein that helps cancer cells gro…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Magnifying the fight against gum disease: loupe vs microscope
Disease control Recruiting nowResearchers compare two magnification tools, dental loupes and a dental operating microscope, during non-surgical deep cleaning for stage 3 periodontitis. Thirty adults with the disease receive scaling and root planing on different areas of the mouth, one area cleaned with loupes…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Weekly shot aims to melt away pounds in obesity fight
Disease control Recruiting nowResearchers are testing a new once-weekly injection called NNC0487-0111 in about 400 Japanese adults with overweight or obesity. Half the participants receive the drug and half receive a placebo, assigned by chance. The main goal is to measure how much body weight changes over th…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Engineered t cells take aim at stubborn leukemias in early trial
Disease control Recruiting nowThis early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to halt lung damage in autoimmune patients
Disease control Recruiting nowThis study tests whether the drug nerandomilast can slow lung scarring in people with autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults whose lung function hasn't improved with standard treatment will take either nerandomilast or a placebo twice daily…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising new combo tackles tough leukemia
Disease control Recruiting nowThis study tests a new mix of drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML). The treatment combines a targeted drug (venetoclax) with two chemotherapy drugs, then switches to another chemo drug plus venetoclax. The goal is to see if this ap…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising new combo therapy for infant leukemia shows potential
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can improve outcomes for infants with a type of leukemia called acute lymphoblastic leukemia (ALL). About 153 infants will participate. The goal is to see if these combinatio…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Braces vs. clear aligners: which is gentler on your gums?
Disease control Recruiting nowThis trial asks whether clear aligners are kinder to gum health than traditional braces during the first three months of orthodontic treatment. Thirty healthy adults with mild crowding will receive either braces or clear aligners, after all participants get a standard teeth clean…
Sponsor: Ravan Mammadov • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New transplant recipe targets tough leukemia
Disease control Recruiting nowThis study is for people with a high-risk type of leukemia called CMML. It tests a stronger chemotherapy combination (including thiotepa) given before a stem cell transplant from a donor. The goal is to see if this approach helps patients live longer without the cancer coming bac…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
A plant compound may help young teeth heal themselves
Disease control Recruiting nowThis trial tests whether a plant-derived compound called asiaticoside, placed inside the tooth, can improve the revascularization process in immature permanent teeth with dead nerves. Researchers will compare asiaticoside to the standard calcium hydroxide medication. The goal is …
Sponsor: Mansoura University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and an advanced cancer that has spread or cannot be removed by surgery. It tests the safety and effectiveness of the immunotherapy drug nivolumab, given alone or…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare blood cancer: experimental drug targets mast cells
Disease control Recruiting nowThis study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…
Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for AML patients: Triple-Drug combo targets Tough-to-Treat leukemia
Disease control Recruiting nowThis study tests whether adding pivekimab sunirine to the standard drugs venetoclax and azacitidine helps adults with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. About 660 participants will be randomly assigned to receive ei…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug AZD5492 tested for autoimmune diseases in first human study
Disease control Recruiting nowThis Phase 1 trial tests the safety and tolerability of a new drug called AZD5492 in 72 adults with lupus, myositis, or rheumatoid arthritis. Participants receive one or two doses under the skin and are monitored for side effects and how the drug moves through the body. The study…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immune cells harvested from tumors could fight advanced cancers
Disease control Recruiting nowThis early-stage trial tests a personalized cell therapy called lifileucel for people with advanced uveal melanoma (a rare eye cancer) or certain sarcomas (connective tissue cancers). The treatment involves removing immune cells from the patient's tumor, growing them in a lab, an…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for kids with tough leukemia: chemo combo trial launches
Disease control Recruiting nowThis early-phase trial is testing a combination of two drugs—Hyper-CVAD chemotherapy and venetoclax—in 22 children and young adults whose leukemia has returned or not responded to treatment. The main goal is to find a safe dose and monitor side effects. If the combination proves …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in earl…
Phase 1/2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a simple injection dissolve painful calcium lumps in rare diseases?
Disease control Recruiting nowThis study tests whether injecting sodium thiosulfate directly into abnormal calcium deposits can shrink them and reduce pain. It includes people with three rare conditions: systemic sclerosis, dermatomyositis, and a genetic disorder called iPPSD2. Participants receive up to 11 i…
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a new oral drug take on hard-to-treat leukaemia?
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called AMX-883, taken by mouth, for people with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. The study will first test AMX-883 alone, th…
Phase 1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill could ease severe childhood arthritis
Disease control Recruiting nowThis study tests a new oral medication, upadacitinib, in children aged 1 to 17 with active systemic juvenile idiopathic arthritis (sJIA), a rare and serious form of arthritis that can affect the whole body. About 90 participants will receive either upadacitinib or the standard in…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThis study tests whether using stem cells from both a half-matched family donor and a cord blood donor can improve survival without cancer returning. It is for people with certain high-risk blood cancers like leukemia or myelodysplastic syndromes. The approach aims to control the…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug takes aim at Treatment-Resistant leukemia
Disease control Recruiting nowResearchers are comparing olverembatinib, an experimental drug, with bosutinib, an approved drug, in adults with chronic phase chronic myeloid leukemia (CML-CP). The trial enrolls patients whose disease has not responded well to at least two prior targeted treatments. A separate …
Phase 3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a monthly antibiotic shot keep kids with leukemia safer from infections?
Disease control Recruiting nowThis early-phase trial is testing whether a long-acting antibiotic called dalbavancin, given once every 28 days along with a short course of oral antibiotics, can prevent serious bloodstream infections in children and young adults with high-risk leukemia. The study will enroll 29…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill takes on tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study tests an oral drug called AUTX-703 in 34 adults with relapsed or hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goal is to check safety and find the right dose. It's an open-label trial, meaning everyone knows they'r…
Phase 1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for young AML patients: targeted drug combo tested in phase 2 trial
Disease control Recruiting nowThis study tests two different drug combinations for younger adults with a specific type of acute myeloid leukemia (CBF-AML). One group gets standard chemotherapy plus a targeted antibody, while the other gets the same chemotherapy plus a newer targeted pill. The goal is to see w…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowThis study tests a one-time injection called VIA Disc NP for people with long-term low-back pain caused by disc disease. The injection adds material to the damaged disc to help cushion it. About 496 adults will receive either the real injection or a sham procedure, and researcher…
Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug tulisokibart aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new medicine called tulisokibart for people with active psoriatic arthritis, a condition causing joint pain and skin plaques. Researchers will compare different doses of the drug to a placebo in 140 adults to see if it improves symptoms like joint tenderness an…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new drug called BGB-11417 (sonrotoclax) in people with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or related blood cancers. The drug works by blocking a protein that helps cancer cells survive. The trial will give the drug alone or toge…
Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe and effective for people with advanced head and neck cancer. Ipatasertib may help stop cancer cell growth. About 46 participants will receive the combinati…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug tulisokibart aims to ease back pain and stiffness in ankylosing spondylitis
Disease control Recruiting nowThis study tests whether tulisokibart can improve symptoms of radiographic axial spondyloarthritis, a type of arthritis that causes pain and swelling in the spine and pelvis. About 315 adults with active disease will receive either the drug or a placebo for 16 weeks. Researchers …
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal paste fights bacteria better?
Disease control Recruiting nowResearchers compare two intracanal medicaments, calcium hydroxide and a calcium silicate-based paste, in 56 adults with acute apical abscesses in single-rooted teeth. They place each medicament inside the cleaned root canal for 7 to 10 days. Bacterial samples are taken before and…
Sponsor: Ataturk University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New immune cell therapy aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis early-phase trial tests whether giving patients a special infusion of donor immune cells (with certain T and B cells removed) after a stem cell transplant is safe and can help prevent their blood cancer from coming back. The study enrolls high-risk patients with hard-to-trea…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo targets tough leukemia in phase II trial
Disease control Recruiting nowThis phase II study is testing a combination of two drugs, enasidenib and azacitidine, in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The trial enrolls 50 adults with a specific IDH2 gene mutation. The goal is to see if the combinati…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for rare blood cancer: targeted drug enters final testing
Disease control Recruiting nowThis study tests a new drug, INCA033989, against the best current treatments for people with a rare blood cancer called essential thrombocythemia who have a specific gene mutation (CALR). About 426 adults who have already tried at least one prior therapy will be randomly assigned…
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Phase 2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
A balloon that coats heart arteries in drug, no stent left behind
Disease control Recruiting nowResearchers are testing whether a balloon catheter coated with the drug sirolimus can safely open narrowed coronary arteries in adults with heart disease. The balloon inflates to press the drug into the artery wall, aiming to keep the vessel open without leaving a permanent stent…
Sponsor: Tonic Medical, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug ABBV-519 enters first human tests for lupus and arthritis
Disease control Recruiting nowThis early-stage study tests a single dose of ABBV-519 in 30 adults with moderate lupus or rheumatoid arthritis. Researchers will check how the drug moves through the body, how it affects immune cells, and whether it is safe. Participants will be followed for about a year to moni…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug MK-1045 enters early human testing for lupus and RA
Disease control Recruiting nowThis early study tests a new medicine, MK-1045, in about 21 people with lupus or rheumatoid arthritis. The main goal is to see if it is safe and tolerable at different dose levels. Participants receive the drug through an IV infusion, and researchers monitor for side effects.
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail targets tough blood cancers
Disease control Recruiting nowThis study tests a combination of three drugs—ivosidenib, venetoclax, and azacitidine—in people with blood cancers like acute myeloid leukemia (AML) that have a specific IDH1 mutation. The goal is to see if the combo is safe and works better than current treatments. About 96 adul…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Mayo clinic tests if adding a scope improves hip surgery outcomes
Disease control Recruiting nowThis study compares two surgical approaches for hip dysplasia: the standard periacetabular osteotomy (PAO) alone versus PAO combined with hip arthroscopy. Researchers will enroll 106 people aged 15-55 with mild or no arthritis. The goal is to see if adding arthroscopy leads to be…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Robots join the rehab team: a new hope for regaining movement?
Disease control Recruiting nowThis trial tests whether adding robotic rehabilitation devices to standard physiotherapy can improve arm and leg function in adults with movement problems from stroke, spinal cord injury, traumatic brain injury, or orthopedic surgery. Participants will receive robotic-assisted se…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for tough leukemia? early trial of debio 1562M begins
Disease control Recruiting nowThis early-phase trial is testing a new drug called Debio 1562M in about 134 people with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The study first checks safety and finds the right dose, then looks at whether the drug can shrink the can…
Phase 1/2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is testing whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent graft-versus-host disease (a common complication where donor cells attack the patient's body) while still being effective. The trial involves 260 adults with b…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug duo targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called rezatapopt combined with the standard drug azacitidine in 24 adults with a specific type of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has a TP53Y220C mutation. The main goal is to check safety and find the b…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combo targets tough blood cancers
Disease control Recruiting nowThis phase 2 trial tests a drug called olutasidenib combined with other targeted therapies for people with relapsed or hard-to-treat blood cancers that have a specific IDH1 mutation plus other signaling mutations. The study aims to see how safe and tolerable these drug combinatio…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New cord blood transplant recipe aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a standardized, optimized approach to cord blood transplantation for adults with high-risk blood cancers like leukemia and lymphoma. The method includes specific chemotherapy, radiation, and stem cell dosing, followed by careful monitoring. Researchers hope to im…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robotic suit restore walking after stroke or spinal injury?
Disease control Recruiting nowThis trial tests whether a powered leg exoskeleton called ZEPU AI9 can safely and effectively help people with walking difficulties caused by stroke, incomplete spinal cord injury, or orthopedic surgery. Participants will be randomly assigned to receive either exoskeleton-assiste…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Robotic leg trainer put to the test for restoring gait after paralysis and surgery
Disease control Recruiting nowThis trial tests whether adding a robotic leg-training device (ZEPU-AI5) to standard rehab can safely improve walking, strength, and balance in adults aged 18–60 with lower-limb problems from stroke, incomplete spinal cord injury, or orthopedic surgery. Participants will receive …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Experimental gene therapy offers hope for fatal nerve disease
Disease control Recruiting nowThis study tests a gene therapy for GM1 gangliosidosis, a fatal disorder that destroys nerve cells. The therapy uses a harmless virus to deliver a working gene, helping the body produce a missing enzyme. Up to 54 children with Type I (ages 6-12 months) or Type II (ages 1-12 years…
Phase 1/2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill aims to keep blood cancer away after transplant
Disease control Recruiting nowThis study tests a daily pill called olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. The goal is to see if the drug is safe and tolerable as maintenance therapy. About 31 participants will take the…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase
Disease control Recruiting nowThis study tests a new drug called sonelokimab for adults with active psoriatic arthritis who have not improved with or cannot take standard TNF-blocker medications. About 600 participants will receive either sonelokimab, a placebo, or an existing drug (risankizumab) for comparis…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New combo aims to boost lung cancer treatment in patients with bone metastases
Disease control Recruiting nowThis phase 2 trial tests whether adding the drug narlumosbart and precise radiation therapy to standard first-line treatment can help people with advanced non-small cell lung cancer that has spread to the bones. The study will enroll 27 adults who have not had prior systemic ther…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Robot trainer aims to restore walking after neurological injury
Disease control Recruiting nowThis study tests whether a robotic device called ZEPU-AI3 can safely help people with lower limb weakness from stroke, spinal cord injury, or orthopedic surgery improve their walking. Participants receive either standard rehabilitation alone or standard rehab plus robot-assisted …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for AML patients in india: drug combo aims for remission without intensive chemo
Disease control Recruiting nowThis study tests a combination of two drugs, venetoclax and azacitidine, in about 100 adults in India with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy. The goal is to see if the combo can put the cancer into remissio…
Phase 4 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a Blood-Derived gel help rebuild bone lost to gum disease?
Disease control Recruiting nowThis study tests whether adding injectable platelet-rich fibrin (i-PRF) to a standard bone graft helps fill in bone defects caused by advanced gum disease. Sixteen adults with stage III periodontitis will receive either the combo treatment or the graft alone during surgery. Resea…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can robots help rebuild movement after stroke or injury?
Disease control Recruiting nowThis trial tests whether robotic devices that guide arm and leg movements can safely improve strength, coordination, and daily function in adults with movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions. Participants will use the devices thre…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robot help people walk again after stroke or injury?
Disease control Recruiting nowThis study tests a robotic device called ZEPU-AI1 that helps people with leg weakness practice standing and walking. The trial includes adults aged 19 to 60 who have walking problems from stroke, spinal cord injury, or orthopedic surgery. Half of the participants will use the rob…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combination targets Hard-to-Treat blood cancers
Disease control Recruiting nowResearchers are testing an experimental drug called LP-108, a BCL-2 inhibitor, combined with azacitidine in adults with acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. The trial aims to find the highest dose people can tolerate and the best …
Phase 1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug aimed at genetic weakness in blood disorders
Disease control Recruiting nowThis study tests a drug called olutasidenib in people with certain early blood conditions (CCUS, lower-risk MDS, or CMML) that have a specific IDH1 gene change. The goal is to see if the drug can control the disease and is safe. About 15 participants will take the drug and be mon…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a robotic glove restore hand function after stroke or injury?
Disease control Recruiting nowThis pilot trial asks whether adding a robotic hand-training device to standard rehabilitation is safe, practical, and helpful for people with arm and hand motor problems caused by stroke, incomplete spinal cord injury, traumatic brain injury, or orthopedic conditions. Participan…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New triple therapy targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—olutasidenib, decitabine, and venetoclax—in people with acute myeloid leukemia (AML) that has a specific IDH1 gene mutation. The goal is to find a safe and effective dose for those whose cancer has returned or not responded to treatme…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill shows promise for rare joint tumor in early trial
Disease control Recruiting nowThis phase 2 trial tests a daily oral drug called pimicotinib in 20 Japanese adults with tenosynovial giant cell tumor (TGCT) that cannot be removed by surgery. The study aims to see if the drug is safe, how it moves through the body, and whether it shrinks tumors. Participants t…
Phase 2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New cartilage patch could help teens with knee damage avoid Long-Term pain
Disease control Recruiting nowThis study tests whether a lab-grown cartilage implant (MACI) works better than a standard surgery (microfracture) for teens aged 10-17 with knee cartilage damage. About 45 participants will receive either treatment and be followed for improvements in pain and sports function. Th…
Phase 3 • Sponsor: Vericel Corporation • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New antibody therapy targets rare blood cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new drug called JNJ-88549968, a bispecific antibody designed to direct the body's immune T cells to attack cancer cells with a specific CALR mutation. The trial will enroll about 220 adults with essential thrombocythemia or myelofibrosis who carry t…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for leukemia patients: experimental drug combo enters late-stage trial
Disease control Recruiting nowThis study tests an experimental drug called BL-M11D1 combined with either standard chemotherapy or another targeted therapy in 216 adults newly diagnosed with acute myeloid leukemia (AML). The goal is to see if the combination is safe and works better at controlling the cancer. …
Phase 2/3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nose cells could fix your knee: new implant trial launches
Disease control Recruiting nowThis phase II trial tests whether an implant made from a patient's own nasal cartilage can treat patellofemoral osteoarthritis (knee arthritis) better than standard platelet-rich plasma injections. 75 adults aged 18–65 with moderate knee arthritis will be randomly assigned to rec…
Phase 2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
School tooth decay study aims to personalize Kids' dental care
Disease control Recruiting nowThis study tests different sequences of minimally invasive dental treatments—like silver diamine fluoride, sealants, and fluoride varnish—plus a hygiene program, to see which works best for children aged 5 to 13 in schools. The goal is to reduce the number of kids who don't respo…
Phase 3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Which dental framework keeps bacteria at bay?
Disease control Recruiting nowResearchers compare two materials for making fixed full-arch dental prostheses supported by four implants in people with no natural teeth in the lower jaw. Each participant receives a prosthesis with either a Zantex (fiber-reinforced polymer) or zirconia (ceramic) framework. The …
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Spinal fluid antibody shots tested for fresh spinal cord injuries
Disease control Recruiting nowResearchers are testing an experimental human monoclonal antibody called NG004 in people who have recently sustained an acute incomplete cervical spinal cord injury. Participants receive repeated injections of NG004 directly into the spinal fluid. The trial's main goal is to chec…
Phase 1 • Sponsor: NovaGo Therapeutics AG • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New spine cage aims to improve back surgery outcomes
Disease control Recruiting nowThis study compares a new spine cage device (MDT-0123) to a standard bone graft for patients needing two-level spinal fusion in the lower back. About 140 adults with disc degeneration or spinal deformity will be enrolled in Japan. The main goal is to see if the device leads to be…
Phase 3 • Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Virtual reality powered by muscle signals could transform stroke rehab
Disease control Recruiting nowThis pilot study tests whether a virtual-reality system controlled by muscle activity can help improve arm and hand movement in people recovering from stroke or spinal cord injury. Participants use a wearable device that detects muscle signals through sensors on the skin and prov…
Sponsor: Imperial College London • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a targeted pill boost chemo for tough blood cancer?
Disease control Recruiting nowThis Phase 3 trial tests whether adding the drug venetoclax to standard chemotherapy helps adults with newly diagnosed acute myeloid leukemia (AML) or a related high-risk condition. About 650 participants aged 18 to 75 will receive either venetoclax or a placebo alongside chemo. …
Phase 3 • Sponsor: University of Ulm • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowThis study tests the long-term safety and effectiveness of an oral drug called zasocitinib (TAK-279) in adults with active psoriatic arthritis, a condition causing joint pain and skin patches. About 1,182 participants who completed a one-year parent study will take either a lower…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study is testing an experimental drug called pivekimab sunirine in about 18 children whose acute myeloid leukemia (AML) has come back or not responded to standard treatments. The main goals are to check the drug's safety and how it moves through the body. Partici…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new treatment for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to recognize and attack cancer cells…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Second chance: vyxeos targets tough leukemia after standard chemo fails
Disease control Recruiting nowThis study tests a drug called Vyxeos in adults with acute myeloid leukemia (AML) whose cancer did not go away after standard chemotherapy. Vyxeos combines two chemo drugs inside a tiny fat bubble (liposome) to deliver them more effectively. The trial will check for side effects …
Phase 1/2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for Still's disease: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new medicine called MAS825 for people with Still's disease, a rare inflammatory condition causing fever, rash, and joint pain. About 20 children and adults with active disease will receive the drug to see if it safely controls symptoms. The goal is to improve d…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug called SAR448501 (DR-0201) in 62 adults with lupus or rheumatoid arthritis. The drug is a bispecific antibody designed to target the immune system. The main goal is to check safety and find the right dose, not yet to prove it works. Partici…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug trial aims to control arthritis in kids
Disease control Recruiting nowThis study is testing a drug called secukinumab, given as an IV infusion, in 20 children aged 2 to 17 with juvenile psoriatic arthritis. The main goals are to see how the drug moves through the body and to check its safety over up to 6 years. This is an early-stage trial, so it f…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis pain in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether the experimental drug zasocitinib (TAK-279) can reduce joint swelling and pain in people with active psoriatic arthritis. About 600 adults will receive either the drug or a placebo for up to 60 weeks. The main goal is to see if more people on the …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug combo targets resistant leukemia
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find a safe dose of momelotinib when given with gilteritini…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nanoparticles boost radiation against tough brain tumors
Disease control Recruiting nowThis study tests whether adding AGuIX gadolinium-based nanoparticles to standard brain radiation can better control brain metastases that are at high risk of coming back. About 134 adults with certain cancers (like melanoma, lung, breast, or colorectal) that have spread to the br…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New antibody GEN3018 enters first human tests for tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has come back or stopped responding to treatment. The main goal is to check safety and find the right dose. Up to 78 parti…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for rare sarcomas: chemo plus immunotherapy combo enters phase III trial
Disease control Recruiting nowThis Phase III trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (doxorubicin) helps people with advanced dedifferentiated liposarcoma or undifferentiated pleomorphic sarcoma live longer without their cancer worsening. About 365 adults whose…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Nano-ink gel could replace repeated skull surgeries for kids with rare genetic disorders
Disease control Recruiting nowThis early-stage study aims to develop a personalized treatment for children with syndromic craniosynostosis, a group of rare genetic disorders where skull bones fuse too early. The approach uses a nano-engineered gel to deliver custom genetic medicine directly to the affected ar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Weight-Loss drug added to arthritis therapy shows promise in new trial
Disease control Recruiting nowThis study looks at whether adding tirzepatide (a weight-loss drug) to standard ixekizumab treatment helps adults with active psoriatic arthritis who are overweight or obese. About 200 participants will receive both medications for up to 12 months. The goal is to see if this comb…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a robotic suit help kids with neurological conditions walk better?
Disease control Recruiting nowThis trial is testing a robotic exoskeleton called ABLE Kids to see if it is safe and practical for children who have trouble walking due to conditions like cerebral palsy, spinal cord injury, or muscle weakness. Fifteen children will use the device in up to ten one-hour training…
Sponsor: ABLE Human Motion S.L. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a bone marrow injection save young hips after fracture?
Disease control Recruiting nowThis trial tests whether injecting a person's own bone marrow into a hip fracture site helps the bone heal faster and more completely. Adults aged 18 to 55 with a specific type of hip fracture will receive either standard screw fixation alone or screw fixation plus a bone marrow …
Sponsor: Yaser Alkanash • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug could reduce Blood-Letting for polycythemia vera patients
Disease control Recruiting nowThis phase 3 trial tests whether adding the drug sapablursen to standard treatment helps people with polycythemia vera, a blood disorder causing too many red blood cells. About 250 participants who currently need regular blood removal (phlebotomy) will receive either sapablursen …
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for stiff lungs? drug trial targets scarring from autoimmune disease
Disease control Recruiting nowThis phase 3 trial tests whether belimumab (Benlysta) can stabilize or improve lung function in adults with interstitial lung disease caused by connective tissue diseases like rheumatoid arthritis or lupus. About 440 participants will receive either belimumab injections or a plac…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a simple knee sleeve slow arthritis and ease pain?
Disease control Recruiting nowThis study tests whether wearing a knee sleeve daily for five years can slow the progression of knee arthritis and reduce pain in adults aged 50 to 64 who have had knee pain for at least three months. Participants are randomly assigned to either wear a knee sleeve every day or no…
Sponsor: Margaret L Gourlay, MD, MPH • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame rare childhood leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, trametinib and azacitidine, for children newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get just these two drugs, while higher-risk patients also receive standard chemotherapy. Th…
Phase 1/2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Triple drug cocktail targets tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs—ASTX727, venetoclax, and gilteritinib—for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome that has a FLT3 mutation. The drugs work in different ways to stop cancer cells from growing. The trial aims to f…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Spinal cord zap may help people breathe again after neck injury
Disease control Recruiting nowThis trial tests whether a device that sends mild electrical pulses to the spinal cord can help people with a cervical spinal cord injury breathe more independently. Twenty adults with a C1-C5 injury who need a ventilator will have electrodes implanted near the injury site and re…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo aims to control rare blood cancer in High-Risk patients
Disease control Recruiting nowThis study tests a combination of two drugs, azacitidine and enasidenib, in people with a high-risk blood cancer called myelodysplastic syndrome (MDS) that has a specific genetic change (IDH2 mutation). The goal is to see if the drugs can stop cancer growth and improve outcomes. …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Tooth enamel regrown with a gel? a new trial explores a drill-free fix for early decay.
Disease control Recruiting nowThis pilot trial tests a gel called Epinamel that aims to regrow tooth enamel naturally by using minerals from saliva. It includes 20 people who just had their braces removed and have white spot lesions—early signs of decay—on both sides of their mouth. The gel is applied to one …
Sponsor: Mintech Bio Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Experimental drug combo aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs—peposertib and a low-dose form of the chemotherapy doxorubicin—in people with advanced sarcomas that have spread or can't be removed by surgery. The goal is to find the safest dose and see if the combo can shrink tumors or s…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Supercharged immune cells take on resistant blood cancers
Disease control Recruiting nowThis study tests a new type of immune cell therapy for people with myeloid cancers (like AML or MDS) that have come back or not responded to treatment. The cells are taken from donated cord blood, engineered to better recognize and attack cancer cells, and given after chemotherap…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Spine disc injection could ease back pain without surgery
Disease control Recruiting nowThis Phase 3 trial tests whether a single injection of IDCT (rebonuputemcel), a cell therapy, can safely reduce pain and disability in people with mild to moderate lumbar disc degeneration. About 162 adults with chronic low back pain will receive either the cell injection or a sh…
Phase 3 • Sponsor: DiscGenics, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for kids with tough leukemia: oral drug combo enters human testing
Disease control Recruiting nowThis early-phase trial is testing a combination of two oral drugs—venetoclax and decitabine/cedazuridine—in children and teens whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. The study aims to find the safest dose and check for early signs tha…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new pill rescue patients when standard leukemia drugs stop working?
Disease control Recruiting nowThis phase 3 trial tests the drug radotinib in adults with chronic-phase chronic myeloid leukemia (CML) who have not responded to or could not tolerate earlier treatments such as imatinib. Participants take radotinib twice daily, and researchers measure how well it reduces leukem…
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for kids with tough leukemias: experimental combo trial opens
Disease control Recruiting nowThis phase 1 study is testing a combination of three drugs—ziftomenib, venetoclax, and azacitidine—in children and young adults (ages 2 to 21) with acute leukemia that has returned or not responded to treatment. The main goal is to find the safest dose of ziftomenib when given wi…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a custom healing cap preserve gum and bone after tooth extraction?
Disease control Recruiting nowThis study tests whether placing an implant immediately after extracting a damaged molar, along with a custom-made healing abutment, helps preserve the surrounding gum and bone. Researchers will group participants by the shape of the empty tooth socket and track tissue volume, im…
Sponsor: Plovdiv Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New CML drug asciminib under Real-World study
Disease control Recruiting nowThis study is watching how well asciminib works and how safe it is in adults with a type of blood cancer called chronic myeloid leukemia. It includes people who are newly diagnosed or have already tried one other treatment. The main goal is to see how many patients reach a very l…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy may free gaucher patients from lifelong infusions
Disease control Recruiting nowThis Phase 3 trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. The goal is to see if a single dose can keep blood counts stable so patients can stop their regular enzyme replacement or substrate reduction therapy. The study will enroll 45 people who…
Phase 3 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental drug plus radiation aims to tackle returning head and neck cancers
Disease control Recruiting nowThis early-phase trial is testing whether a drug called camonsertib, combined with a precise type of radiation, can help control head and neck cancers that have come back or cannot be removed by surgery. About 39 adults with these cancers will receive the drug along with focused …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New injection aims to stop bladder leaks in spinal cord injury patients
Disease control Recruiting nowThis early study tests a single treatment of EG110A injections into the bladder muscle for adults with spinal cord injury who still have bladder leaks despite standard care. The goal is to see if the treatment is safe and can reduce incontinence. Sixteen participants will be foll…
Phase 1/2 • Sponsor: Cyllene Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could less be more? new trial shortens leukemia drug course for seniors
Disease control Recruiting nowThis study looks at whether giving the drug venetoclax for a shorter time, along with the combination drug ASTX727, works as well as the usual longer course for adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who are not healthy enough for strong chemot…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental cell shot aims to boost brain repair in kids with rare metabolic diseases
Disease control Recruiting nowThis early-stage trial tests whether adding special cells (DUOC-01) into the spinal fluid is safe for children with inherited metabolic diseases that damage the brain. Participants are ages 1 week to 21 years and are already receiving a standard umbilical cord blood transplant. T…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new pill shrink the spleen in myelofibrosis?
Disease control Recruiting nowThis early-stage trial tests an experimental pill called WJ01024 in people with myelofibrosis, a bone marrow disorder that often causes an enlarged spleen. The study has two parts: one gives WJ01024 alone to patients whose previous JAK inhibitor treatment stopped working, and the…
Phase 1 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug takes aim at autoimmune diseases in early human test
Disease control Recruiting nowThis early-stage study tests an experimental drug called LY4298445 in healthy volunteers and people with lupus or rheumatoid arthritis. The main goal is to check safety and how the body handles the drug. Participants will receive either the drug or a placebo, and the study lasts …
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could fewer pills mean same relief for rheumatoid arthritis?
Disease control Recruiting nowThis trial tests whether people with rheumatoid arthritis who have stable disease can stop taking methotrexate or leflunomide while continuing their TNF inhibitor, restarting the drug if needed. Researchers compare this approach to staying on the combination therapy. They track d…
Phase 4 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Genetic roadmap guides new hope for tough leukemia
Disease control Recruiting nowThis study screens people with acute myeloid leukemia (AML) for specific genetic markers to assign them to a treatment sub-study with a targeted drug or combination. It aims to improve response rates by personalizing therapy based on each person's cancer profile. The trial enroll…
Phase 2/3 • Sponsor: Beat AML, LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for kids with psoriatic arthritis: apremilast trial begins
Disease control Recruiting nowThis Phase 3 study tests whether the drug apremilast (Otezla) can safely reduce joint inflammation and pain in children aged 5 to 17 with active juvenile psoriatic arthritis. About 60 participants will receive either apremilast or a placebo pill for 16 weeks. The main goal is to …
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo hopes to improve myelofibrosis treatment
Disease control Recruiting nowThis early-phase trial is testing whether adding abemaciclib to the standard drug ruxolitinib is safe and effective for people with myelofibrosis, a type of bone marrow cancer. The study will enroll 18 adults who have been on ruxolitinib for at least 12 weeks. Researchers will mo…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for Hard-to-Treat blood cancers: SLS009 trial launches
Disease control Recruiting nowThis study tests a new drug called SLS009, alone or with other medicines, in people with blood cancers like leukemia and lymphoma that have come back or not responded to treatment. It also includes newly diagnosed patients with high-risk leukemia. The goal is to see if the drug i…
Phase 1/2 • Sponsor: Sellas Life Sciences Group • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Weekly shot could replace daily growth hormone for kids
Disease control Recruiting nowThis phase 3 trial compares a once-weekly growth hormone injection (lonapegsomatropin) to a daily one (somatropin) in 186 prepubertal children with growth failure due to Turner syndrome, SHOX deficiency, being small for gestational age, or idiopathic short stature. The goal is to…
Phase 3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for AML patients who fail venetoclax?
Disease control Recruiting nowThis pilot study tests the drug olutasidenib, with or without azacitidine, in 25 adults with a specific type of acute myeloid leukemia (IDH1-mutated) that has returned or not responded after venetoclax treatment. The goal is to see if the cancer can be brought into remission. Par…
Phase 2 • Sponsor: Timothy Pardee • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to standard chemotherapy before a stem cell transplant can help prevent cancer from returning in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 participants aged 12 to 6…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Knee surgery boosted with bone marrow? new trial investigates
Disease control Recruiting nowThis study looks at whether adding a bone marrow injection to standard knee surgery can improve pain and function for people with cartilage or meniscus injuries. Fifty adults aged 18 to 64 will be randomly assigned to get either the bone marrow injection or a placebo saltwater in…
Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Brain chip breakthrough: paralysis patients may control devices with thought
Disease control Recruiting nowThis study tests a brain implant that records and stimulates brain areas to help adults with severe paralysis (from spinal cord injury, ALS, or stroke) control assistive devices like computers or wheelchairs. The main goal is to check safety, and researchers will also see if part…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single cell therapy calm multiple autoimmune diseases?
Disease control Recruiting nowThis trial tests an investigational cell therapy called FT839 in people with active autoimmune diseases, including ANCA-associated vasculitis, inflammatory myositis, rheumatoid arthritis, lupus, and systemic sclerosis. Participants receive FT839 as two intravenous infusions, some…
Phase 1/2 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a targeted pill boost standard therapy for hard-to-treat leukemia?
Disease control Recruiting nowThis phase 3 trial is testing whether adding revumenib, a drug that blocks a protein called menin, to the usual two-drug combination (azacitidine and venetoclax) can improve outcomes for adults newly diagnosed with acute myeloid leukemia (AML) that has a specific genetic change (…
Phase 3 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug DSB2455 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called DSB2455 in adults with advanced cancers (breast, ovarian, prostate, pancreatic, or brain metastases) that have a specific DNA repair problem. The main goals are to check safety and see if the drug shrinks tumors. About 180 participan…
Phase 1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New trial aims to find safer chemo for stem cell transplants in leukemia patients
Disease control Recruiting nowThis study tests two chemotherapy drugs, treosulfan and melphalan, given before a stem cell transplant in 220 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to see which drug works better at helping patients survive longer with fewer side …
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kids with leukemia: drug trial targets cancer control
Disease control Recruiting nowThis study tests a drug called asciminib in children aged 1 to 18 with a specific leukemia (Ph+ CML-CP). The goal is to see if the drug can control the cancer by reducing the number of cancer cells. About 50 children will take the drug, and researchers will check how well it work…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill combo offers hope for older leukemia patients who Can't handle chemo
Disease control Recruiting nowThis study tests whether taking two oral medications (decitabine and ivosidenib) together can control acute myeloid leukemia (AML) in patients aged 60+ or those too frail for standard chemo. About 50 participants will take the pills in 28-day cycles until the disease worsens or s…
Phase 2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a smartphone app replace physiotherapy for knee pain?
Disease control Recruiting nowThis trial tests whether a smartphone app-guided rehabilitation program (MOKneeTOR) is as effective as traditional hospital-based physiotherapy for people with knee osteoarthritis. Participants will be randomly assigned to either use the app for 24 weeks or attend outpatient phys…
Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new drug pair beat standard chemotherapy for tough AML?
Disease control Recruiting nowThis trial tests whether the combination of venetoclax and azacytidine works better than the standard chemotherapy regimen of daunorubicin plus cytarabine in adults aged 18 to 64 with newly diagnosed acute myeloid leukemia that has adverse risk features. Participants are randomly…
Phase 2/3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to cut blood removal in rare cancer
Disease control Recruiting nowThis trial tests rusfertide, an injected drug, in Japanese adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal is to see if rusfertide can keep red blood cell levels under control and reduce the need for phlebotomy (blood removal). Al…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study tests a new drug called TQH3906 for people with active psoriatic arthritis, a condition causing joint pain and skin patches. About 156 adults will receive either TQH3906, a placebo, or an existing drug (tofacitinib) for 12 weeks. The main goal is to see if TQH3906 impr…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard medications (cyclophosphamide and tacrolimus) can prevent severe graft-versus-host disease (GVHD) in people receiving stem cell transplants for blood cancers like leukemia. About 124 adults will receive the drug com…
Phase 2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New combo aims to fight relapsed leukemia after transplant
Disease control Recruiting nowThis study tests a combination of a PD-1 inhibitor (camrelizumab), a chemotherapy drug (azacitidine), and donor immune cells (DLI) in 43 adults with acute myeloid leukemia that has returned after a stem cell transplant. The goal is to see if this approach can help patients achiev…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for rare cartilage disease: five drugs put to the test
Disease control Recruiting nowThis study tests five different standard immune-suppressing drugs to see which works best for controlling relapsing polychondritis, a rare disease that causes painful inflammation of cartilage. About 20 adults will receive one of the drugs and be monitored for 26 weeks. The goal …
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New shoulder implant tracked for 10 years in 300 patients
Disease control Recruiting nowThis study is testing a shoulder replacement device in 300 people with shoulder arthritis, bone death, or rotator cuff tears. Participants receive the implant and are followed for 10 years to see how well it works and if it is safe. The goal is to improve pain and shoulder functi…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug combo aims to tame stubborn psoriatic arthritis
Disease control Recruiting nowThis study tests whether adding deucravacitinib to standard therapy helps adults with psoriatic arthritis that is not well controlled. About 128 participants will receive the combination and be monitored for 48 weeks. The goal is to reduce skin and joint symptoms and improve qual…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug miRisten targets Tough-to-Treat leukemia in early trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called miRisten in 12 adults whose acute myeloid leukemia (AML) has come back or not responded to prior treatments. The drug works by blocking a molecule that helps cancer cells grow. The main goal is to check safety and find the best …
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called NT-175 for people with advanced solid tumors (like lung, colon, or breast cancer) that have a specific mutation (TP53 R175H) and a certain immune marker (HLA-A*02:01). NT-175 is made from a patient's own immune cells, which are …
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New engineered graft aims to improve stem cell transplants for kids with leukemia
Disease control Recruiting nowThis study tests a specially engineered donor graft called Orca-Q in children and young adults with blood cancers who need a stem cell transplant. The graft is designed to help the new cells take hold and reduce complications. The trial is currently on hold, but aims to enroll 40…
Phase 1/2 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill could boost leukemia treatment for patients with specific gene changes
Disease control Recruiting nowThis phase 3 trial tests whether adding the drug bleximenib to standard chemotherapy helps adults with a certain genetic type of acute myeloid leukemia (AML). About 875 people will get either bleximenib or a placebo alongside chemo, then be followed for 4 years. The goal is to se…
Phase 3 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Single surgery dental implants: bone ring technique could cut treatment time in half
Disease control Recruiting nowThis study tests a surgical technique called the Bone Ring Technique (BRT) for placing dental implants in people with severe bone loss in the upper jaw. Normally, this requires two separate surgeries over many months, but BRT combines sinus lifting and implant placement into one …
Sponsor: Damascus University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy for rare blood cancers put on hold
Disease control Recruiting nowThis phase 2 trial compares a drug combo (ASTX727 plus iadademstat) against ASTX727 alone for people with advanced myeloproliferative neoplasms (MPNs), a group of rare blood cancers. The study aims to see if adding iadademstat improves complete response rates. However, the trial …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for kids with joint pain: risankizumab trial launches
Disease control Recruiting nowThis study tests a drug called risankizumab in children with juvenile psoriatic arthritis, a condition causing joint pain and swelling. About 40 kids will receive either risankizumab or the standard drug adalimumab for 24 weeks, with responders continuing for up to 2 years. The g…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new biologic ease rheumatoid arthritis when standard drugs fail?
Disease control Recruiting nowThis phase 2 trial tests whether telitacicept, an experimental biologic given as a weekly injection, can improve symptoms in people with difficult-to-treat rheumatoid arthritis. Participants receive either telitacicept plus standard therapy or standard therapy alone for 24 weeks.…
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can tiny beads block pain signals from arthritic spine joints?
Disease control Recruiting nowThis trial tests a procedure called trans-arterial embolization for people with chronic back pain caused by facet joint arthritis. Doctors inject tiny beads into the blood vessels feeding the painful joints to reduce blood flow and potentially ease pain. The study includes 40 adu…
Sponsor: Northwell Health • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can home exercises straighten scoliosis as well as a therapist?
Disease control Recruiting nowThis trial tests whether doing Schroth exercises at home works as well as doing them with a physiotherapist for teenagers with mild to moderate scoliosis. Participants aged 10-18 with a spinal curve between 10 and 45 degrees will be randomly assigned to either supervised or home-…
Sponsor: Bitlis Eren University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy targets tough blood cancers
Disease control Recruiting nowThis early-stage trial tests a combination of two drugs, ivosidenib and ruxolitinib, in people with advanced blood cancers (MPNs) that have an IDH1 mutation. The main goal is to find the safest dose and see if the combo helps control the disease. About 18 adults will take part.
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a new toothpaste tame gum disease by keeping good bacteria happy?
Disease control Recruiting nowThis pilot study tests a new toothpaste designed to protect the natural balance of bacteria in the mouth. 28 adults with periodontitis will brush twice daily for 3 months while continuing their usual gum disease care. Researchers will check if the toothpaste improves oral health …
Sponsor: Periotrap Pharmaceuticals GmbH • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can an immunotherapy combo shrink sinonasal tumors before surgery?
Disease control Recruiting nowThis trial tests whether adding the immunotherapy drug toripalimab to standard chemotherapy before surgery can help people with sinonasal cancer, a rare cancer of the nasal cavity and sinuses. Participants receive toripalimab along with carboplatin and docetaxel, then undergo sur…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill could help kids with dwarfism grow – but early days
Disease control Recruiting nowThis study tests a daily oral drug called TYRA-300 in 92 children aged 3–10 with achondroplasia (a common form of dwarfism). The goal is to see if it safely increases their growth rate. Researchers will try different doses to find the best one. It's a Phase 2 trial, so it's still…
Phase 2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids: drug may prevent transplant complications
Disease control Recruiting nowThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who are getting a bone marrow transplant. GVHD is a serious complication where donor cells…
Phase 2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a helmet or simple repositioning reshape an Infant's head?
Disease control Recruiting nowThis trial tests two ways to correct flat head syndrome in infants: caregiver-led repositioning and a custom-fit helmet. Researchers will measure head shape changes in treated infants and compare them with a group of typically developing infants. Infants with torticollis will als…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Vitamin c boost: could high doses help treat a tough blood cancer?
Disease control Recruiting nowThis early-stage trial is testing whether adding high-dose vitamin C (given through an IV) to the usual two-drug combination (azacitidine and venetoclax) is safe and effective for people newly diagnosed with acute myeloid leukemia who cannot handle intensive chemotherapy. About 3…
Phase 1 • Sponsor: Kittika Poonsombudlert • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo aims to tackle tough leukemia
Disease control Recruiting nowThis early-phase study tests a new drug called lonitoclax combined with azacitidine in 66 adults whose acute myeloid leukemia has returned or not responded to prior treatment. The main goal is to find a safe dose and check for early signs that the combination might help control t…
Phase 1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat kidney cancer
Disease control Recruiting nowThis early-stage study tests a new drug called casdatifan (AB521) alone or combined with other cancer drugs in people with advanced clear cell kidney cancer or other solid tumors. The main goals are to check safety and find the right dose. About 362 participants will take part.
Phase 1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a targeted drug combo replace harsh chemo for NPM1 leukemia?
Disease control Recruiting nowThis trial tests whether a combination of venetoclax and azacitidine can work as well as or better than standard intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia that has an NPM1 mutation. Participants are aged 18 to 70 and healthy enough for intensiv…
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A smarter brace for scoliosis: does 3D design stop curves from worsening?
Disease control Recruiting nowThis trial compares a 3D-designed Boston brace with the standard Boston brace in 170 teens with idiopathic scoliosis, a spinal curve affecting about 3% of children. Participants wear the brace 20 hours a day until they reach skeletal maturity. Researchers measure whether the 3D b…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a pill plus injection tame a tough blood cancer?
Disease control Recruiting nowThis study looks at how well a combination of two drugs—venetoclax (a pill) and azacitidine (an injection)—works for adults newly diagnosed with acute myeloid leukemia (AML), a cancer of the blood and bone marrow. The participants are people who are older or have health issues th…
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a targeted pill keep leukemia from returning after transplant?
Disease control Recruiting nowThis phase II trial is testing whether the drug ivosidenib, taken as a pill, can help prevent relapse in people with acute myeloid leukemia (AML) or myelodysplastic neoplasia (MDS) who have an IDH1 mutation and have recently undergone a stem cell transplant. Participants will sta…
Phase 2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Mind over matter: can a wireless brain implant restore control for the paralyzed?
Disease control Recruiting nowThis trial is testing an implantable wireless brain-computer interface (BCI) in people with tetraplegia caused by cervical spinal cord injury. The device is designed to read brain signals and translate them into commands to control external devices, such as a computer cursor or a…
Sponsor: BCIFlex Medical Technology Co., Ltd. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can your own bone marrow beat steroids for knee pain?
Disease control Recruiting nowThis trial tests whether a single injection of a patient's own bone marrow concentrate (BMAC) can reduce knee pain and improve function better than the standard corticosteroid injection in people with knee osteoarthritis. Adults aged 18-70 with moderate knee arthritis and persist…
Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a hong kong robotic system perfect knee alignment with any implant?
Disease control Recruiting nowThis trial tests whether a new robotic system, KUNWU®, can accurately achieve the planned knee alignment during total knee replacement, regardless of which of two implant types is used. Adults with knee osteoarthritis needing surgery will be randomly assigned to receive either th…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Digital exercise: a new weapon against joint inflammation?
Disease control Recruiting nowThis trial tests whether a remotely supervised exercise program can reduce disease activity in people recently diagnosed with axial spondyloarthritis, a type of inflammatory arthritis affecting the spine and joints. Participants will follow a personalized plan with high-intensity…
Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a tropical tea shrink blood cancers?
Disease control Recruiting nowThis pilot study tests whether drinking tea made from soursop leaves can reduce the number of cancer cells in people with relapsed or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) — blood cancers that have not responded to standard treatments. About 20 particip…
Early phase 1 • Sponsor: Roger Strair • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a diabetes drug ease knee pain and stave off surgery?
Disease control Recruiting nowThis trial tests whether adding metformin, a common diabetes medication, to a program of diet and exercise can reduce knee pain and improve function in overweight or obese adults with knee osteoarthritis. Participants will receive either metformin or a placebo for six months, alo…
Early phase 1 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can trained immune cells stop blood cancer relapse?
Disease control Recruiting nowThis trial tests whether giving patients special immune cells, called TAA-T, after a stem cell transplant can help prevent high-risk blood cancers like acute myeloid leukemia from coming back. The cells are designed to recognize three common tumor markers and attack any remaining…
Phase 1 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a gut microbiome transplant ease axial spondyloarthritis?
Disease control Recruiting nowThis trial tests whether transferring gut bacteria from a healthy donor (fecal microbiota transplantation, or FMT) can reduce disease activity in people with axial spondyloarthritis (axSpA) who haven't fully responded to biologic therapy. Participants receive a single enema with …
Phase 2 • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can advanced imaging reveal hidden swallowing muscle damage in IBM?
Diagnosis Recruiting nowResearchers at Johns Hopkins University are studying whether neuromuscular ultrasound and MRI can serve as reliable markers of swallowing muscle problems in people with inclusion body myositis (IBM). The study compares imaging and clinical findings in 30 participants, including p…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
5-Minute MRI could solve brain tumor mystery after radiation
Diagnosis Recruiting nowThis study is testing a new, quick MRI technique called Magnetic Resonance Fingerprinting (MRF) to better tell the difference between a brain tumor coming back and damage from radiation therapy (radiation necrosis). About 90 people will take part, including healthy volunteers, pa…
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
New scanner could help surgeons pinpoint the right discs to treat
Diagnosis Recruiting nowThis study tests a tool called NOCISCAN that uses a special type of MRI to find which discs in the lower back are causing pain. About 300 adults who are already planning back surgery will take part. Half of the surgeons will see the NOCISCAN results, and half will not, to see if …
Sponsor: Aclarion • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can two simple questionnaires capture how bad sinus disease feels?
Diagnosis Recruiting nowResearchers at 32 medical centers in Europe, the USA, and South Africa are testing two new questionnaires designed to measure how severe chronic rhinosinusitis feels and how well it is controlled. About 1,000 patients with chronic rhinosinusitis, with or without nasal polyps, fil…
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
A new brain scan tracer aims to light up myelin damage
Diagnosis Recruiting nowResearchers at Yale University are testing a PET imaging tracer called [18F]3F4AP to see whether it can measure demyelination, the loss of the protective myelin sheath around nerve fibers. The study includes healthy volunteers and people with conditions such as multiple sclerosis…
Phase 1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New screening tool aims to catch hidden arthritis in psoriasis patients
Diagnosis Recruiting nowThis Canadian study tests whether adding two questions about morning stiffness and lower back pain to a standard screening tool (PEST) can help dermatologists identify psoriatic arthritis earlier in people with moderate-to-severe plaque psoriasis. About 502 adults who are candida…
Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Can a simple blood test catch Cushing's earlier?
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose Cushing's syndrome, a condition caused by too much cortisol. Researchers will test the accuracy of the desmopressin stimulation test in 140 people aged 18-70 who have or may have Cushing's, plus healthy volunteers. Participants will…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a simple wash stop the bacteria behind shoulder surgery infections?
Prevention Recruiting nowResearchers are testing whether washing the surgical site with antimicrobial solutions after the first cut lowers the amount of Cutibacterium acnes, a bacterium commonly found on the skin, during shoulder replacement surgery. Adults scheduled for a first shoulder replacement are …
Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Jawbone rescue: can a Blood-Based membrane save your smile after a tooth comes out?
Prevention Recruiting nowWhen a tooth is removed, the jawbone underneath can shrink, which may make it harder to place a dental implant later. This trial tests two methods to limit that bone loss: one uses a bone graft plus a membrane made from the patient's own blood (platelet-rich fibrin), and the othe…
Sponsor: Danae A. Apatzidou • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Chewing gum to prevent premature births? major trial underway in malawi
Prevention Recruiting nowThis study tests whether chewing xylitol gum during pregnancy can reduce the risk of preterm birth and low birthweight. 6,000 pregnant women in Malawi will chew either a high or low dose of xylitol gum or a placebo gum. The goal is to see if improving oral health with xylitol lea…
Phase 2/3 • Sponsor: University of Washington • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Pill vs shot: testing a simpler way to stop deadly clots after spinal cord injury
Prevention Recruiting nowPeople who suffer spinal cord injuries face a high risk of dangerous blood clots, and doctors usually prescribe enoxaparin, a daily injection, to prevent them. This trial compares enoxaparin with apixaban, an oral blood thinner, in 60 adults recovering from spinal cord injury at …
Sponsor: Loewenstein Hospital • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Sugar compound in dental wipes may shield kids with leukemia from deadly infections
Prevention Recruiting nowThis phase 3 trial tests whether xylitol dental wipes can reduce bloodstream infections in children with acute myeloid leukemia (AML). Xylitol, a natural sugar that limits mouth bacteria growth, is applied via wipes during chemotherapy. The study will compare infection rates betw…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Can virtual visits replace In-Person pain care for rural patients?
Symptom relief Recruiting nowThis study tests whether virtual lifestyle-focused pain care works as well as in-person care for adults with chronic back, knee, or hip pain living in rural areas. Participants will receive up to 10 sessions over six months, either in-person with a physiotherapist or virtually wi…
Sponsor: University of Sydney • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New nasal spray aims to ease sinus troubles in teens
Symptom relief Recruiting nowThis study tests whether a nasal spray called OPN-375 can reduce symptoms of chronic sinusitis (like stuffy nose, discharge, and facial pain) in adolescents aged 12 to 17. About 84 teens will receive either the spray or a placebo twice daily for 12 weeks. The main goal is to see …
Phase 3 • Sponsor: Optinose US Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Massive pain trial aims to find new relief options
Symptom relief Recruiting nowThis Phase 2 trial is testing four experimental drugs (taken orally or by IV) against placebo in 10,000 people with chronic pain from knee osteoarthritis, diabetic nerve damage, or low-back pain. The goal is to see if any of these drugs can safely reduce pain. The study uses a fl…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves zap knee pain without needles
Symptom relief Recruiting nowThis study tests a device that uses focused sound waves to block pain signals in the knee, offering a needle-free option for people with chronic osteoarthritis pain. Ten adults with moderate to severe knee pain will receive a one-hour treatment and be followed for six months. The…
Sponsor: FUSMobile Inc. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New knee shot aims to ease arthritis pain without surgery
Symptom relief Recruiting nowThis study tests a new injection called CartiPRO to see if it can safely reduce knee pain in people with osteoarthritis. About 194 adults will receive either CartiPRO or another approved injection, and then get a second shot 24 weeks later. Researchers will measure pain and knee …
Sponsor: DALIM TISSEN Co., Ltd. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
A 3D-Printed bone replica could save the ankle joint
Symptom relief Recruiting nowAvascular necrosis of the talus happens when the ankle bone loses its blood supply and collapses. Researchers are testing a custom-made implant shaped like the patient's own talus to replace the damaged bone. The study follows 50 adults for five years to see whether the implant r…
Sponsor: Paragon 28 • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New needle technique aims to ease back pain in ankylosing spondylitis
Symptom relief Recruiting nowThis study tests a new, ultrasound-guided acupotomy technique to improve symptoms in people with ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 60 adults with active disease will receive the treatment to see if it reduces pain and improves …
Sponsor: China-Japan Friendship Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could CBD help spinal cord injury patients regain bladder control?
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD), a compound from cannabis, can reduce urinary incontinence in people with recent spinal cord injury. Twenty adults with at least two leaks per day will take a purified CBD drug (Epidiolex) twice daily for 90 days. The main goal is to see…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Gender-Sensitive therapy: a new hope for knee osteoarthritis?
Symptom relief Recruiting nowThis study tests a 6-week physiotherapy program designed to improve pain, function, and joint awareness in adults with knee osteoarthritis. The program uses sensory modulation and graded weight-bearing exercises, and the trial compares outcomes between male and female participant…
Sponsor: Shifa Tameer-e-Millat University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Lavender massage may soothe arthritis pain, new study says
Symptom relief Recruiting nowThis study tests whether adding lavender aromatherapy massage to standard care can reduce pain and improve wrist movement in people with rheumatoid arthritis. About 100 adults with stable medication will be randomly assigned to get the massage or not. Researchers will measure pai…
Sponsor: University of Baghdad • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New gel injection aims to soothe sore tendons
Symptom relief Recruiting nowThis study is testing a gel called OSTENIL TENDON to see if it safely reduces pain and improves movement in people with tendon problems. Researchers will enroll 84 adults with one of four types of tendinopathy. The main goal is to measure pain changes three months after treatment…
Sponsor: TRB Chemedica AG • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Spinal implant aims to restore bladder control after paralysis
Symptom relief Recruiting nowResearchers are testing whether epidural electrical stimulation can improve bladder function in people with spinal cord injuries. The trial enrolls adults with injuries above T11 who have trouble urinating and rely on catheters. Participants receive an implanted spinal cord stimu…
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A new ankle? researchers track 400 people with an implant meant to restore movement
Symptom relief Recruiting nowResearchers are studying the Exactech Vantage Mobile-Bearing Total Ankle System, an implant used to replace a damaged ankle joint. The study enrolls 400 adults with ankle arthritis or related joint failure who are scheduled for total ankle replacement. Participants receive the im…
Sponsor: Exactech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a new ankle implant keep people moving for a decade?
Symptom relief Recruiting nowResearchers are studying the Exactech Vantage Total Ankle System, an implant used to replace a damaged ankle joint in people with arthritis or a failed previous replacement. The study enrolls 370 adults who are candidates for total ankle replacement and follows them for up to 10 …
Sponsor: Exactech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a nasal spray help spinal cord injury? new safety trial begins
Symptom relief Recruiting nowThis early-stage study is checking if insulin nasal spray is safe for people with spinal cord injury. Up to 12 adults who had an injury at least 4 months ago will use the spray or a placebo daily for up to 24 days. Researchers will monitor side effects and see if virtual training…
Phase 1 • Sponsor: HealthPartners Institute • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Hip surgery pain targeted with nerve block in new trial
Symptom relief Recruiting nowResearchers are testing whether a nerve block called a PENG block reduces pain after periacetabular osteotomy, a major hip realignment surgery. In the study, 90 adults scheduled for this surgery receive either ropivacaine, a local anesthetic, or a saline placebo injected around s…
Phase 4 • Sponsor: Matias Vested • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Brain training for the spine: new study aims to reduce spasticity and boost walking
Symptom relief Recruiting nowThis study tests a behavioral training program that teaches people with chronic spinal cord injury to reduce a specific leg reflex. The goal is to decrease spasticity and improve walking speed and distance. 25 participants will train for about 6 months, with researchers measuring…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New app aims to ease mental strain for veterans with spinal injuries and their families
Symptom relief Recruiting nowThis study tests a mobile health app called iMHere 2.0 designed to help veterans with spinal cord injury and their family caregivers manage stress and improve well-being. Researchers will work with 100 participants to gather feedback and tailor the app to their needs. The goal is…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
CBD trial aims to ease sanfilippo syndrome symptoms
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD) can safely improve behavior, mood, sleep, and daily function in people with Sanfilippo syndrome, a rare genetic disorder. Thirty-five participants will receive either CBD or a placebo, then switch after a break. Caregivers will report on…
Phase 2/3 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can talk therapy and symptom tracking ease the trauma of leukemia?
Symptom relief Recruiting nowThis study tests a program called EASE that combines psychological support with regular symptom checks and early access to palliative care. Researchers want to see if it reduces traumatic stress and physical symptoms in people newly diagnosed with acute leukemia. Half of the 266 …
Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New twist on old muscle relaxant aims to ease sciatica pain in days
Symptom relief Recruiting nowThis study tests whether a modified version of the muscle relaxant metaxalone (640 mg) can reduce low back and leg pain in people with acute sciatica or spinal stenosis. Fifty adults aged 18 to 80 with new-onset pain will take either the drug or a placebo for 7 days. Researchers …
Phase 4 • Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Knee replacement pain showdown: local injection vs nerve blocks
Symptom relief Recruiting nowThis study compares two pain relief methods for people undergoing total knee replacement: injecting numbing medicine into the knee area versus blocking several nerves around the knee. The goal is to see which method reduces the need for strong painkillers like opioids in the firs…
Sponsor: CMC Ambroise Paré • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Does the order of bone grafting change how well dental implants take?
Symptom relief Recruiting nowResearchers compare two ways of sequencing bone grafting during sinus lift and dental implant placement in the upper jaw. One sequence places the implant before packing bone graft; the other packs the graft first, then drills for the implant. Both use a customized surgical guide …
Sponsor: Cairo University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Robot vs surgeon: which knee replacement works better?
Symptom relief Recruiting nowThis study compares two types of total knee replacement surgery for people with knee osteoarthritis: one done manually and one assisted by a robotic device (VELYS). About 346 participants will be randomly assigned to one of the two surgeries and followed for a year to see which l…
Sponsor: Golden Jubilee National Hospital • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Pure oxygen tested as a switch for dormant nerves after spinal cord injury
Symptom relief Recruiting nowResearchers at the University of Alberta are testing whether breathing pure oxygen for two minutes at a time can change sensation and movement in adults with long-standing, severe spinal cord injuries. The study enrolls 25 people aged 18 to 65 whose injuries occurred at least thr…
Early phase 1 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can spinal stimulation plus intense training help children injured at birth move better?
Symptom relief Recruiting nowResearchers at the University of Louisville are studying children who have a cervical spinal cord injury that happened before or during birth. The study combines activity-based recovery training, which uses tasks like stepping and standing, with transcutaneous spinal cord stimula…
Sponsor: University of Louisville • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can adding Shoulder-Blade training boost neck pain relief?
Symptom relief Recruiting nowResearchers are testing two physical therapy approaches for adults aged 40 to 60 with chronic neck pain and confirmed cervical spondylosis. Both groups do deep neck flexor training guided by a pressure biofeedback device, and one group also adds shoulder-blade stabilization exerc…
Sponsor: Ibadat International University, Islamabad • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Steroid shots during knee replacement: which route works best?
Symptom relief Recruiting nowResearchers are testing whether giving the steroid dexamethasone during total knee replacement helps with pain, nausea, and recovery, and whether it matters if the drug goes into a vein or is injected around the knee joint. The trial enrolls 159 adults with knee osteoarthritis ha…
Phase 4 • Sponsor: Christian Candrian • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Pre-transplant workout may shield heart in older leukemia patients
Symptom relief Recruiting nowThis study tests a home-based exercise program called CAREFit-BMT for people with high-risk acute myeloid leukemia who are about to have a stem cell transplant. The program includes aerobic and strength training to improve heart function before the procedure. Researchers will enr…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Dentists test three sealers to find the most comfortable root canal
Symptom relief Recruiting nowThis study compares three different root canal sealers—AH Plus, ProRoot Bio Sealer, and BC Sealer ion+—to see which one leads to the least pain after treatment. About 135 adults with irreversible pulpitis in a lower molar will be randomly assigned to one of the three sealers. Pat…
Sponsor: European University of Lefke • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can collagen shots around the heel tendon speed recovery?
Symptom relief Recruiting nowAchilles tendinopathy is a painful condition of the tendon at the back of the ankle. Researchers are testing whether injecting a collagen-based medical device around the tendon, combined with a physiotherapy program of eccentric strengthening exercises, improves pain and function…
Sponsor: Guna S.p.a • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Knee replacement pain relief showdown: which numbing cocktail wins?
Symptom relief Recruiting nowThis study tests three different numbing medicine combinations for pain after total knee replacement. 90 adults having knee surgery will get one of three options: a long-acting numbing drug, or a standard numbing drug plus one of two additives. The goal is to see which approach r…
Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could an Anti-Gravity treadmill make knee arthritis physiotherapy work better?
Symptom relief Recruiting nowResearchers are testing whether adding gait re-education on an R-Force anti-gravity treadmill to standard physiotherapy helps adults with knee osteoarthritis. The trial enrolls 80 people aged 40 to 70 who have radiologically confirmed knee arthritis and ongoing knee pain. Partici…
Sponsor: University of Rzeszow • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Sinus surgery without opioids: can dexmedetomidine do the job?
Symptom relief Recruiting nowResearchers are studying whether skipping opioids during functional endoscopic sinus surgery leads to better recovery. The trial follows 104 adults with chronic sinusitis who receive anesthesia with dexmedetomidine and other non-opioid pain relievers instead of standard opioid dr…
Sponsor: Filiz Kaya • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New thumb implant could speed recovery from arthritis surgery
Symptom relief Recruiting nowThis study compares two surgical treatments for rhizarthrosis, a type of arthritis at the base of the thumb. One group gets a new prosthesis (HORUS implant), the other gets the standard trapezectomy. Researchers will measure hand function and pain in 50 patients over the short te…
Sponsor: Clinique Bizet • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a leg nerve zap help kids with spina bifida go Drug-Free?
Symptom relief Recruiting nowThis study tests a small, home-use device that sends mild electrical pulses to a nerve in the leg (tTNS) to improve bladder control in 20 children with spina bifida who have neurogenic bladder. Half the kids will use the real device, half a sham device, for 30 minutes daily, 5 da…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New combo therapy aims to ease knee pain without heavy lifting
Symptom relief Recruiting nowThis study tests whether combining blood-flow-restricted exercise (light exercise with a cuff on the leg) and pain education can reduce pain and improve movement in people with knee osteoarthritis. About 90 adults aged 40 and older with knee osteoarthritis will take part. The goa…
Sponsor: University of Hail • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
A shot to straighten a smile: botulinum toxin tested in kids with facial asymmetry
Symptom relief Recruiting nowThis trial tests whether botulinum toxin type A injections can improve lower-lip asymmetry in children with hemifacial microsomia, a condition where the lower lip moves unevenly during smiling or speaking. The study enrolls children under 18 with this condition and a crooked-mout…
Sponsor: Peking Union Medical College • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Frozen shoulder patients may get relief by working out the other arm
Symptom relief Recruiting nowThis study tests whether cross training—exercising the healthy arm—can improve pain, function, and mobility in people with frozen shoulder, without directly working the painful shoulder. About 38 adults aged 18-65 with unilateral frozen shoulder will be randomly assigned to stand…
Sponsor: Inonu University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New electrode design may extend pain relief for common back condition
Symptom relief Recruiting nowThis study tests whether a newer multi-tined electrode provides longer pain relief than a standard single-tip electrode during radiofrequency ablation for lumbar spondylosis, a common cause of lower back pain. About 25 adults with chronic lower back pain from worn facet joints wi…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can physical therapy beamed into rural homes ease arthritis pain?
Symptom relief Recruiting nowResearchers at the University of Alberta are comparing two virtual physical therapy programs with usual care for rural adults who have hip or knee osteoarthritis and are not waiting for joint replacement surgery. Participants first continue their usual arthritis care for 12 weeks…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Surgeons test augmented reality to Fine-Tune knee replacement cuts
Symptom relief Recruiting nowResearchers are testing whether an augmented reality guidance system helps surgeons make more accurate bone cuts and align knee implants during total knee replacement. The study enrolls about 50 adults with advanced osteoarthritis who are scheduled for a primary knee replacement …
Sponsor: Foundation for Orthopaedic Research and Education • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Bone marrow injection may offer longer hip pain relief than steroids
Symptom relief Recruiting nowThis study tests whether a single injection of concentrated bone marrow cells can reduce pain and improve function in people with hip osteoarthritis better than a standard steroid injection. One hundred adults with moderate to severe hip arthritis will be randomly assigned to rec…
Phase 3 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Simple leg workouts may ease knee pain and improve sleep
Symptom relief Recruiting nowThis study tests whether a program that strengthens the quadriceps and calf muscles can improve walking, reduce pain, and enhance sleep in people with knee osteoarthritis. About 52 adults aged 40-60 with moderate knee arthritis will be randomly assigned to either the exercise pro…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Fish or puppets: which distraction works best for needle-phobic kids?
Symptom relief Recruiting nowThis trial tests whether two simple distractions — watching a betta fish or playing with a hand puppet — can lower pain, fear, and anxiety in children aged 5 to 7 during a blood draw. One group will use the fish, another the puppet, and a third will receive standard care. Researc…
Phase 1 • Sponsor: Igdir University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a Flat-Sided dental file mean less pain after a root canal?
Symptom relief Recruiting nowResearchers at Minia University are testing whether the shape of a single-file rotary dental instrument affects how much debris gets pushed out of the root tip during a root canal, and whether that changes how much pain patients feel afterward. Thirty teeth with irreversible pulp…
Sponsor: Minia University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Could a simple mist replace needles for kids' post-surgery pain?
Symptom relief Recruiting nowThis study tests whether giving a numbing medicine (bupivacaine) as a mist before surgery can lower pain and the need for extra painkillers in children aged 1-7 having cleft palate repair. Half the children get the mist, half get a placebo, and neither the doctors nor families kn…
Phase 3 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Sugar water vs. anesthetic: which injection eases knee arthritis best?
Symptom relief Recruiting nowThis study will follow 86 adults with knee osteoarthritis to see if injections of sugar-water (dextrose) or local anesthetic around the knee nerves provide better pain relief and function. Participants will be assessed for six months after their routine injection. The goal is to …
Sponsor: Ankara Training and Research Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Skin-Deep spinal stimulation: can zapping the spine help people walk again?
Symptom relief Recruiting nowResearchers at the University of Washington are testing whether non-invasive electrical stimulation of the spinal cord through the skin, combined with intensive physical therapy, can improve walking and standing in people with spinal cord injuries. The trial enrolls 20 adults wit…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Steroid shot before shoulder replacement may cut pain and hospital time
Symptom relief Recruiting nowThis study tests whether giving a steroid (dexamethasone) during shoulder replacement surgery can improve recovery. Researchers will measure pain, nausea, shoulder movement, and how long patients stay in the hospital. The study involves 74 adults with shoulder arthritis who are h…
Phase 4 • Sponsor: Christian Candrian • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New daily pill could ease knee pain and help weight loss in obesity
Symptom relief Recruiting nowThis study tests a once-daily pill called orforglipron in 800 adults with obesity or overweight who also have painful knee osteoarthritis. The goal is to see if the drug reduces knee pain and improves physical function over about 74 weeks. Participants will be randomly assigned t…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New weekly shot aims to ease arthritic knee pain and shed pounds
Symptom relief Recruiting nowThis Phase 3 study tests a once-weekly injection called eloralintide in 900 adults with osteoarthritis of the knee who are also overweight or obese. The goal is to see if it reduces knee pain and helps with weight loss compared to a placebo. Participants will be in the study for …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Inside or outside the knee: which steroid injection spot eases arthritis pain better?
Symptom relief Recruiting nowThis trial compares two injection sites for steroid shots in people with moderate-to-severe knee osteoarthritis. Participants get the injection on either the inside or outside of the knee, then report pain and function over 12 weeks. The goal is to see if one spot provides better…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New pill could ease osteoarthritis knee pain without surgery
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental oral drug, LY4065967, for knee pain caused by osteoarthritis. About 150 adults with chronic knee pain and confirmed osteoarthritis will receive either the drug or a placebo. The main goal is to see if the drug safely reduces pain intensity…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a Screen-Based tai chi class soothe aching knees?
Symptom relief Recruiting nowThis trial tests whether remote tai chi, taught through web-based sessions twice a week for 12 weeks, can reduce knee pain in adults aged 50 and older with knee osteoarthritis. Researchers compare adding remote tai chi to routine care against routine care alone, measuring pain, p…
Sponsor: Tufts Medical Center • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a smart platform ease the toll of childhood cancer on families?
Symptom relief Recruiting nowThis trial tests two digital platforms, one for children with cancer and one for their parents, designed to improve communication with healthcare providers and address physical, emotional, social, and spiritual needs during treatment. Researchers will recruit 120 families of chil…
Sponsor: National Defense Medical University, Taiwan • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can cannabis compounds ease arthritic knees? new trial aims to find out
Symptom relief Recruiting nowThis phase 2 trial is testing whether daily doses of THC, CBD, or both can reduce pain and improve symptoms in people with knee osteoarthritis. About 200 participants will take one of the study drugs or a placebo for 16 weeks, with regular pain assessments, blood tests, and brain…
Phase 2 • Sponsor: Steven E Harte, PhD • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New combo injection aims to soothe arthritic knees
Symptom relief Recruiting nowThis study tests whether injecting a mix of hyaluronic acid and fibrinogen into the knee can reduce pain and improve function in people with knee osteoarthritis. About 31 adults aged 45 to 75 will receive the injection as part of routine care. Researchers will track changes in pa…
Sponsor: Cao Kim Xoa • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Veneers boost smiles and Self-Esteem in kids with rare tooth disorder
Symptom relief Recruiting nowThis study looks at whether putting thin covers (veneers) on the front teeth can improve the daily life of children aged 11-14 who have a rare genetic condition that makes tooth enamel weak and discolored. Researchers will measure changes in oral health, self-esteem, and social c…
Sponsor: Istanbul University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Which injection eases arm pain better: steroid or Anti-Inflammatory?
Symptom relief Recruiting nowThis trial tests two common injections for pain in the shoulder, elbow, wrist, or hand caused by arthritis or tendon problems. One injection is triamcinolone, a corticosteroid that reduces inflammation. The other is ketorolac, a non-steroidal anti-inflammatory drug (NSAID). Parti…
Phase 4 • Sponsor: Emory University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Knee pain breakthrough? hyaluronic acid injections under microscope
Symptom relief Recruiting nowThis study tests whether hyaluronic acid injections into the knee can reduce pain and improve function in people with knee osteoarthritis. Researchers will also measure changes in inflammation-related substances in blood and joint fluid. 50 adults aged 45-75 with moderate knee os…
Sponsor: Istanbul University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Teaching the brain about pain before surgery may ease recovery
Symptom relief Recruiting nowThis trial tests whether adding Pain Neuroscience Education to standard pre-operative physiotherapy helps adults aged 35 to 60 recover better after lumbar spine surgery. Participants scheduled for a laminectomy receive either standard exercises alone or the same exercises plus th…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Smart stimulation: could a new tuning method end chronic pain?
Symptom relief Recruiting nowThis study is for people with chronic back or leg pain who are already scheduled to get a spinal cord stimulator. Researchers want to see if a new method called telefitting can find the best stimulation settings faster and more effectively. Participants will try different stimula…
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New nerve block could ease pain of broken ribs without opioids
Symptom relief Recruiting nowThis study tests two different nerve block methods to control pain in people with multiple broken ribs. The goal is to see which technique provides better pain relief, helps patients breathe deeper, and shortens hospital stays. Thirty-six adults with at least two rib fractures wi…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could a tiny dose of radiation ease your aching knees?
Symptom relief Recruiting nowThis study tests whether low-dose radiotherapy can reduce pain in people with knee osteoarthritis. 128 participants will receive either real radiation or a sham treatment three times a week for two weeks. Researchers will track pain scores and painkiller use for six months to see…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Knee surgery recovery: could a common steroid ease pain and get you moving faster?
Symptom relief Recruiting nowThis study follows 270 adults having knee replacement surgery to see if the steroid dexamethasone (given as a pill or through a vein) helps with early recovery. Researchers will measure pain, mobility, nausea, and need for extra painkillers. The study does not assign treatments—p…
Sponsor: Haseki Training and Research Hospital • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can a Two-Probe technique double the pain relief for knee arthritis?
Symptom relief Recruiting nowThis trial tests whether using two probes during radiofrequency ablation eases knee osteoarthritis pain better than the standard one-probe approach. Radiofrequency ablation uses heat to quiet the nerves that send pain signals from the knee. Researchers will enroll 64 adults over …
Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Could a gentle nerve zap ease jaw pain? new study tests it
Symptom relief Recruiting nowThis pilot study will test whether a non-invasive vagus nerve stimulation (nVNS) device can reduce jaw pain and improve mood in 10 premenopausal women with temporomandibular disorders (TMD). Participants will receive the treatment twice a week for 8 weeks and undergo brain scans,…
Sponsor: Arpana Church • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Weight-loss drug ecnoglutide takes aim at knee osteoarthritis pain
Symptom relief Recruiting nowThis phase 3 trial tests whether ecnoglutide, a GLP-1 drug similar to semaglutide, can reduce knee pain and body weight in obese adults with knee osteoarthritis. Participants receive either ecnoglutide injections or a placebo for several months. The study measures changes in pain…
Phase 3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A Pocket-Sized coach for shoulder surgery recovery?
Symptom relief Recruiting nowThis trial tests whether a personalized mobile app can improve recovery after reverse shoulder replacement surgery. About 170 adults undergoing this procedure will be randomly assigned to either use the interactive app or receive standard care. The main goal is to see if the app …
Sponsor: VieCuri Medical Centre • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Could a sweet drink before surgery speed up recovery?
Symptom relief Recruiting nowThis pilot study tests whether giving teenagers a carbohydrate drink before scoliosis surgery helps them recover faster and feel better. Participants will be randomly assigned to either receive the drink or follow standard fasting rules. The study looks at whether the drink impro…
Sponsor: University of Malaya • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Gum width key to root coverage success, new study finds
Knowledge-focused Recruiting nowThis study looks at how the width of healthy gum tissue affects the success of covering exposed tooth roots in 30 adults with gum recession. Participants will receive a minimally invasive gum graft surgery. The goal is to see if wider gum tissue leads to better root coverage and …
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Is chronic elbow pain really a Whole-Body nerve problem?
Knowledge-focused Recruiting nowLateral epicondylitis, often called tennis elbow, causes pain and tenderness on the outside of the elbow and can linger despite treatment. Researchers are comparing 128 people with chronic lateral epicondylitis to healthy controls to see whether those with elbow pain have lower p…
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Digital sensor maps how jaw surgery moves the jaw joint
Knowledge-focused Recruiting nowResearchers at Semmelweis University are studying how orthognathic surgery, which realigns the upper and lower jaws, affects the temporomandibular joint and jaw movement. Fifty adults aged 18 to 45 with severe dentofacial deformities take part. Using a digital facebow device call…
Sponsor: Semmelweis University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks drug levels in breast milk for nursing moms
Knowledge-focused Recruiting nowThis study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not …
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gum fluid proteins eyed as link between smoking and periodontitis
Knowledge-focused Recruiting nowResearchers are studying whether cigarette smoking is linked to levels of two proteins, MFN1 and NLRP3, in the fluid between the teeth and gums. The study includes 88 adults aged 25 to 65, split into four groups: nonsmokers and smokers with healthy gums, and nonsmokers and smoker…
Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Pregnancy hormone hCG may hold clues to bone and gland health
Knowledge-focused Recruiting nowResearchers are studying whether blood levels of luteinizing hormone (LH) and human chorionic gonadotropin (hCG) are linked to the presence, severity, and long-term outcomes of endocrine disorders such as osteoporosis, thyroid disease, and adrenal gland problems. The study enroll…
Sponsor: Martin Blomberg Jensen • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Tooth pulp test may reveal which deep cavities heal without a root canal
Knowledge-focused Recruiting nowResearchers at a dental institute in India are studying whether levels of two inflammation markers, IL-1beta and IL-6, in the tooth's pulp can predict how well a full pulpotomy works. The procedure removes the inflamed crown portion of the pulp, caps it with a mineral-based mater…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Rare disease study seeks clues for future treatments
Knowledge-focused Recruiting nowThis study tracks the natural course of fucosidosis, a rare genetic disorder, in up to 57 people. It collects medical history and ongoing health data without giving any experimental treatment. The goal is to better understand the disease and help design future therapies.
Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Coin flip chemo: study tests if patients will let a computer choose their treatment strength
Knowledge-focused Recruiting nowThis study looks at whether adults with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy are willing to let a computer randomly assign them to either lower- or higher-intensity treatment. The goal is to see if this approach is acceptable to patients…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Massive shoulder replacement study tracks 20,000 patients for over a decade
Knowledge-focused Recruiting nowThis study is tracking 20,000 people who have had or will have shoulder replacement surgery to see how well the implants work over at least 10 years. Researchers will measure pain, daily function, and strength using standard shoulder scores. The goal is to better understand the l…
Sponsor: Exactech • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
AI could revolutionize thumb arthritis assessment
Knowledge-focused Recruiting nowThis study looks at thumb osteoarthritis, a common cause of pain and weakness at the base of the thumb. Researchers will assess 93 people using a broad approach that includes physical, psychological, and social factors. They will also test whether artificial intelligence can pred…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into mouth bacteria to unlock immune secrets
Knowledge-focused Recruiting nowThis study looks at how genetic immune system problems might lead to gum disease and other mouth issues. Researchers will collect samples like saliva, plaque, and blood from 700 people, including those with immune defects, healthy adults with gum disease, and healthy adults witho…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowThis study is for people with certain autoinflammatory diseases (like NOMID, DIRA, CANDLE, SAVI, and others) and their healthy relatives. Researchers want to learn more about what causes these diseases and how they affect the body over time. Participants will have medical tests a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists watch thyroid conditions unfold in 2,500 patients
Knowledge-focused Recruiting nowThis study follows up to 2,500 people with thyroid problems like hyperthyroidism, hypothyroidism, or Graves' disease. Researchers will track how these conditions develop over time using standard medical tests and genetic samples. The goal is to better understand the natural histo…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Kidney Patients' hidden risks: 1000-Person study aims to predict fractures and heart attacks
Knowledge-focused Recruiting nowThis study will follow 1000 adults with advanced chronic kidney disease (stage 4-5) to learn why they face higher risks of bone fractures and heart disease. Researchers will track bone turnover markers, calcium and phosphate levels, and kidney function over time. No new treatment…
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare bone disease under the microscope: what causes melorheostosis?
Knowledge-focused Recruiting nowThis study follows adults with melorheostosis, a rare disease that causes bone thickening, pain, and joint problems. Researchers will track how the disease progresses over time, collect genetic samples from patients and their relatives, and look for biomarkers. The goal is to bet…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New registry to monitor jaw joint replacements for better care
Knowledge-focused Recruiting nowThis study is a registry that will collect information from about 200 people who receive a total jaw joint (TMJ) replacement. Researchers will track their health, jaw function, and any complications for up to 5 years after surgery. The goal is to learn more about how these replac…
Sponsor: AO Innovation Translation Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can your genes predict eye damage from a common arthritis drug?
Knowledge-focused Recruiting nowThis study looks at whether certain genes make some people more likely to develop eye damage from the drug Plaquenil, which is used for autoimmune diseases like lupus and rheumatoid arthritis. Researchers will compare people who have had eye damage from Plaquenil with those who h…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists study mast cells to unlock mastocytosis mysteries
Knowledge-focused Recruiting nowThis study collects bone marrow and blood samples from up to 600 people with mastocytosis, a condition where too many mast cells cause symptoms like itching and bone pain. Researchers will study what makes these cells grow and survive. The goal is to learn more about the disease,…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for biomarkers to predict spinal stenosis progression
Knowledge-focused Recruiting nowThis study explores whether inflammation from fat tissue around the spine contributes to spinal stenosis, a condition that narrows the spinal canal and causes pain. Researchers will collect tissue and blood samples from 100 patients undergoing spinal surgery to measure levels of …
Sponsor: Poznan University of Physical Education • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare brain diseases to unlock clues for future treatments
Knowledge-focused Recruiting nowThis study follows people with rare genetic disorders that cause harmful substances to build up in the body, leading to brain damage. Researchers will monitor up to 200 participants over time using exams, surveys, and lab tests. The goal is to better understand how these diseases…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Your wisdom teeth could help science: study seeks tissue samples
Knowledge-focused Recruiting nowThis study collects wisdom teeth and surrounding tissue that are normally thrown away after oral surgery. Researchers will use these samples to learn more about oral health and disease. Up to 3,000 people aged 16 to 50 who need their wisdom teeth removed can join. The study also …
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch major study to unravel rare bone disease
Knowledge-focused Recruiting nowThis study follows up to 500 people with polyostotic fibrous dysplasia or McCune-Albright syndrome to learn how these conditions change over time. Researchers will collect medical data and tissue samples to better understand the disease. The goal is to improve future diagnosis an…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Walking study aims to unlock secrets of stiff muscles after stroke
Knowledge-focused Recruiting nowThis study looks at how the Achilles tendon behaves during walking in people with spastic paresis, a condition causing muscle stiffness after stroke or spinal cord injury. Researchers will measure tendon stiffness, length, and volume using ultrasound and motion analysis. The goal…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Joint tissue study aims to personalize rare disease treatment
Knowledge-focused Recruiting nowThis study looks at whether analyzing synovial tissue can help doctors better manage pigmented villonodular synovitis (PVNS), a rare joint disease that causes pain and joint damage. Researchers will collect tissue samples from 30 patients through biopsy or surgery to assess quali…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows people with acquired or inherited bone marrow failure for up to 20 years to learn how the diseases and treatments affect the body over time. Participants, aged 2 and older, will have regular check-ups and tests every 1 to 3 years. The goal is to better understa…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Short bursts of low oxygen may boost breathing after spinal injury
Knowledge-focused Recruiting nowThis study tests whether short episodes of breathing low-oxygen air can improve breathing strength in people with chronic spinal cord injury. Participants will try three different breathing sessions (low oxygen, low oxygen with extra carbon dioxide, and normal air) to see which w…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Scientists track spondyloarthritis in families to uncover clues to severe disease
Knowledge-focused Recruiting nowThis study follows up to 2,000 people with spondyloarthritis (a group of inflammatory joint and spine conditions) and their healthy relatives. Researchers aim to identify symptoms, genetic factors, and medical tests that predict who will develop more severe forms of the disease. …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Real-World data may unlock Pacritinib's true potential in myelofibrosis
Knowledge-focused Recruiting nowThis study looks back at medical records of adults with myelofibrosis who took pacritinib for at least a month. Researchers will track changes in spleen size, blood counts, symptoms, and survival to see how the drug performs in everyday practice. The goal is to understand real-wo…
Sponsor: Swedish Orphan Biovitrum • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can a smartwatch track how kids recover from cancer surgery?
Knowledge-focused Recruiting nowThis study is testing whether smartwatches and blood tests can measure how well children recover after surgery to remove a solid tumor. About 40 children and their caregivers will wear smartwatches and answer questionnaires before surgery and for up to a year after. Researchers w…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can some children with a pointed skull skip major surgery?
Knowledge-focused Recruiting nowTrigonocephaly is a condition where a baby's skull fuses too early along the forehead, giving the head a pointed shape. Doctors often operate to relieve pressure on the growing brain, but some children may do just as well without surgery. This study follows children aged 0 to 8 w…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Telehealth program aims to improve end-of-life conversations for older cancer patients
Knowledge-focused Recruiting nowThis study tests a telehealth program that helps older adults (60+) with blood cancers like leukemia or MDS talk to their doctors about their care wishes. The program also helps them fill out advance directive forms. Researchers want to see if it improves communication and reduce…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Hidden cost of cancer: study probes financial toxicity in sarcoma patients
Knowledge-focused Recruiting nowThis study looks at the financial stress that patients with bone or soft tissue sarcoma face after surgery. Researchers will ask 100 adults to fill out questionnaires about the costs of their cancer care and how that affects their quality of life. No new treatments are being test…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Scientists track rare gene variant to unlock blood disorder mysteries
Knowledge-focused Recruiting nowThis study follows people of all ages who have or may have a RUNX1 gene variant, which can cause bleeding problems and increase the risk of blood cancers. Researchers will collect medical history, blood samples, and bone marrow over many years to understand how the condition deve…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Disposable scope takes on gold standard in pleural diagnosis
Knowledge-focused Recruiting nowThis pilot trial tests whether a single-use flexible bronchoscope can safely and effectively replace the semi-rigid pleuroscope for diagnosing pleural effusion—a buildup of fluid around the lungs. Hospitalized patients needing a tissue sample will be randomly assigned to one of t…
Sponsor: National University of Malaysia • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Blood cancer registry tracks thousands to map disease course
Knowledge-focused Recruiting nowResearchers are building a registry to collect long-term health information from adults with myelodysplastic syndromes and therapy-related acute myeloid leukemia. The study gathers details on blood counts, bone marrow tests, genetic changes, and treatments. By following these pat…
Sponsor: Groupe Francophone des Myelodysplasies • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Gum Surgery's hidden impact: blood tests reveal stress response
Knowledge-focused Recruiting nowThis study looks at how gum surgery changes inflammation markers in the blood. Researchers will take blood samples from 30 adults before, during, and after dental procedures. The goal is to see if surgical stress causes a different inflammatory response compared to non-surgical c…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can paired brain and nerve stimulation strengthen movement pathways after spinal cord injury?
Knowledge-focused Recruiting nowResearchers are studying how aging and spinal cord injury affect two nerve pathways that help control leg movement: the corticospinal and reticulospinal tracts. The trial enrolls adults with chronic spinal cord injury and healthy controls. Participants receive transcranial magnet…
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Why do some joint replacements get infected? moscow study hunts for clues
Knowledge-focused Recruiting nowResearchers in Moscow are studying patients who have knee or hip replacement surgery to learn why some develop serious infections around the implant. The study will follow 750 adults aged 45 and older, checking their immune status, mineral metabolism, and tissue samples before an…
Sponsor: People's Friendship University of Russia • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Vibration and baduanjin put muscle activation under the microscope
Knowledge-focused Recruiting nowResearchers are studying how short bursts of whole-body vibration, vibration combined with plantar stimulation, and a Baduanjin heel-raise exercise affect lower-limb muscle activity in young adults with flat feet and normal feet. Thirty college students will complete all conditio…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Which root canal device kills more bacteria? new study aims to find out
Knowledge-focused Recruiting nowThis study tests three different devices used during root canal treatment to see which one removes the most bacteria from infected teeth. Ninety adults with dead nerves in their premolars will be randomly assigned to one of the three methods. Researchers will measure bacterial le…
Sponsor: Abhishek Parolia • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists investigate rare overgrowth disorder proteus syndrome
Knowledge-focused Recruiting nowThis study aims to understand the genetic and biological causes of Proteus syndrome, a rare condition causing abnormal growth of bones, skin, and other tissues. Researchers will follow up to 1,500 participants over time, using medical exams, imaging, and blood tests to track how …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a less invasive disc surgery mean less pain right after?
Knowledge-focused Recruiting nowThis study looks at whether a newer, minimally invasive endoscopic technique for removing a herniated disc leads to less back pain in the first few days after surgery compared with traditional open surgery. Researchers will follow 140 adults scheduled for lumbar discectomy and me…
Sponsor: Saint-Gregoire Private Hospital Center • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Researchers launch study to unravel mysteries of rare immune disorder sHLH
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop secondary hemophagocytic lymphohistiocytosis (sHLH), a serious immune condition causing fevers and organ damage. Researchers will follow 300 participants for up to 3 years, collecting blood samples and medical data to identify…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can weak muscles slow down hip surgery recovery? new study aims to find out
Knowledge-focused Recruiting nowThis study at Montpellier University Hospital will look at whether low muscle mass and strength before hip replacement surgery affects how well people aged 75 and older regain their independence. About 20 volunteers will have blood tests, scans, and a tiny muscle sample taken dur…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tracks sinus health in kids with cystic fibrosis on breakthrough drugs
Knowledge-focused Recruiting nowThis study follows 80 children aged 2-8 with cystic fibrosis to see how highly effective CF drugs (Kalydeco or Trikafta) impact sinus disease and sense of smell. Researchers will use MRI scans, smell tests, and quality-of-life surveys over two years. The goal is to understand whe…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can sinus surgery help cystic fibrosis lungs? new study investigates
Knowledge-focused Recruiting nowThis study follows 170 adults with cystic fibrosis and chronic sinusitis to see if sinus surgery improves lung function and quality of life compared to medical treatment alone. Participants either have surgery or continue with standard care. Researchers will track changes in brea…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tests if education can reduce heart risks after spinal cord injury
Knowledge-focused Recruiting nowThis study aims to see if a specially designed education module helps people with spinal cord injury (SCI) learn about their increased risk for heart disease, obesity, and metabolic problems. Researchers will enroll 250 adults with SCI and measure changes in knowledge, body weigh…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Estrogen drop may hold clue to bladder leaks in women with spinal cord injury
Knowledge-focused Recruiting nowWomen with spinal cord injury often deal with urinary incontinence, but most research has focused on women after menopause. This pilot study asks whether the natural drop in estrogen after ovulation could make incontinence more frequent. Twenty-four women will track their menstru…
Sponsor: Swiss Paraplegic Research, Nottwil • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can a smartphone replace a dental scanner for implant impressions?
Knowledge-focused Recruiting nowThis trial tests whether a smartphone-based photogrammetry system (T-Marker) can match or beat a specialized intraoral scanner with splinting bodies (IoConnect) for recording implant positions in people with full-arch dental implants. Each participant will be scanned with both me…
Sponsor: Menoufia University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood protein clues may predict chemo success in older cancer patients
Knowledge-focused Recruiting nowThis study looks at 60 adults with acute myeloid leukemia or related blood cancers who are receiving a gentler type of chemotherapy. Researchers will measure certain proteins in the blood to see if they can predict how well the treatment works. The goal is to better understand wh…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can online classes beat Face-to-Face lessons for bone health?
Knowledge-focused Recruiting nowThis study tests whether digital education or in-person classes help people over 50 with osteoporosis take better care of themselves. Six hundred participants will be split into three groups: one gets standard information, another attends three group sessions with a physiotherapi…
Sponsor: University Hospital, Linkoeping • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of pituitary and hypothalamic tumors in children. Researchers will collect blood and tumor samples from up to 2,000 participants to analyze DNA and look for inherited patterns. The study also trains doctors and tests new MRI technique…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Placebo surgery to reveal truth about back pain operations
Knowledge-focused Recruiting nowThis study aims to find out if spinal fusion surgery truly helps people with long-term low back pain. Ninety adults with severe, persistent pain will undergo surgery, but half will receive a placebo procedure without fusion. Neither the patients nor their care team will know whic…
Sponsor: Uppsala University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Blood test may spot worn spinal discs behind chronic back pain
Knowledge-focused Recruiting nowThis study looks at whether a protein called BDNF in the blood matches the degree of spinal disc wear seen on MRI and levels of an inflammation marker called IL-1β. Researchers will measure BDNF in blood samples from 59 people with low back or leg pain caused by disc degeneration…
Sponsor: Keimyung University Dongsan Medical Center • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
NCI opens screening study for experimental cell therapies in multiple cancers
Knowledge-focused Recruiting nowThis study screens adults with certain cancers (like melanoma, lung, or colorectal cancer) to see if they qualify for experimental treatments being tested by the NCI Surgery Branch. These treatments involve taking a patient's own immune cells, growing them in a lab, and giving th…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Veterans with spinal injury may have hidden nerve pathways, new study hopes to find
Knowledge-focused Recruiting nowThis study looks at 40 veterans with chronic spinal cord injury to find any remaining nerve connections below their injury. Researchers will use MRI scans and non-invasive stimulation to measure these connections. The goal is to understand who might benefit from future treatments…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study to see which back procedure keeps seniors out of surgery
Knowledge-focused Recruiting nowThis study will follow 8,000 Medicare patients with lumbar spinal stenosis who receive either the MILD procedure or interspinous process decompression. Researchers will track complications and whether patients need additional surgery within two years. The goal is to see which app…
Sponsor: Stryker Instruments • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
A nationwide effort to map a rare blood Cancer's toll
Knowledge-focused Recruiting nowResearchers in Italy are building a large registry of adults newly diagnosed with myelodysplastic syndromes, a group of blood cancers where the bone marrow does not make enough healthy blood cells. The study will collect data on up to 10,000 people to measure how many new cases o…
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Poor sleep may worsen dental pain, study suggests
Knowledge-focused Recruiting nowThis study looks at whether having insomnia before dental surgery leads to more pain afterward. Adults getting teeth pulled will be grouped by their sleep quality and will report pain levels using questionnaires. The goal is to see if poor sleep makes recovery harder.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a smartphone app help people with spinal cord injury and cerebral palsy take control of their health?
Knowledge-focused Recruiting nowThis study is testing whether a mobile health app system can help people with chronic conditions like spinal cord injury, cerebral palsy, spina bifida, or traumatic brain injury improve their self-management skills and wellness. About 160 participants will use the app for one yea…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
A vast data bank could unlock secrets of bone and muscle diseases
Knowledge-focused Recruiting nowThis study collects and stores medical information from people treated for orthopaedic conditions like osteoarthritis, scoliosis, and cerebral palsy. Researchers at the University of Florida will gather data during routine clinical care to create a resource for future research. T…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Do arthritis drugs sabotage dental implants? new study investigates
Knowledge-focused Recruiting nowThis study looks at how well dental implants heal in people taking TNF-alpha inhibitors (a type of arthritis medication). Researchers will compare 15 patients on these drugs with 15 similar patients not taking them. Participants will get implants and be followed for a year with e…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a simple grip test predict joint replacement recovery?
Knowledge-focused Recruiting nowResearchers at University Hospital Bonn are following 300 adults who undergo knee or hip replacement surgery to understand how their recovery unfolds. The study measures quality of life, hand grip strength, and bone density before and after the procedure. The goal is to identify …
Sponsor: University Hospital, Bonn • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Scientists hunt for clues in blood cancer samples to improve future treatments
Knowledge-focused Recruiting nowThis study is collecting blood, bone marrow, and leftover tissue samples from 550 people with acute myeloid leukemia or follicular lymphoma. Researchers will analyze the samples to find genetic markers that may predict how well treatments work or why some stop working. The goal i…
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Could the mouth reveal clues about juvenile arthritis activity?
Knowledge-focused Recruiting nowThis observational study looks at whether oral health and the bacteria in saliva are linked to disease activity in children with juvenile idiopathic arthritis (JIA). Researchers will compare children with active disease to those in remission, examining their teeth, gums, oral hyg…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New spinal cord injury database aims to unlock secrets of Long-Term complications
Knowledge-focused Recruiting nowThis study is building a detailed collection of medical information and biological samples from 105 people with spinal cord injury. Researchers will track how injuries change over time, what complications arise, and how the body responds. The goal is to create a research platform…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
2000 volunteers help create a gold standard for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer and some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of…
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
NIH launches study to unlock secrets of rare 'Black Urine' disease
Knowledge-focused Recruiting nowThis study aims to learn more about alkaptonuria, a rare genetic disease that causes a pigment to build up in bones and tissues, leading to arthritis and other problems. Researchers will evaluate 300 patients over several years using advanced medical tests. The goal is to better …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
NIH launches Long-Term study to track stem cell transplant survivors
Knowledge-focused Recruiting nowThis study provides ongoing check-ups for people who received a donor stem cell transplant at the NIH at least three years ago. Researchers will monitor for late side effects, disease return, and overall health. Participants will have yearly visits that may include blood tests, b…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can good nutrition boost VR rehab for seniors?
Knowledge-focused Recruiting nowThis study looks at whether malnutrition changes how well older adults recover after shoulder surgery when they use virtual reality (VR) for rehabilitation. Researchers will track 60 frail adults aged 60+ to see if poor nutrition limits the benefits of VR therapy. The goal is to …
Sponsor: Claudio Pedone • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New imaging registry aims to sharpen cancer treatment precision
Knowledge-focused Recruiting nowThis study will collect data from 2,000 patients in the Netherlands and France who are receiving standard, minimally invasive cancer treatments like tumor ablation or catheter-based therapies for liver, lung, kidney, or bone cancers. During these procedures, a special CT scanner …
Sponsor: Mark C Burgmans, MD PhD • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
NIH launches major study to uncover why rheumatic diseases hit minorities harder
Knowledge-focused Recruiting nowThis study aims to learn more about the causes of rheumatic diseases—conditions that cause joint pain, stiffness, and swelling—and why they often affect minority groups more severely. Researchers will observe up to 7,500 adults with known or suspected rheumatic disease, providing…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can genetics predict the course of brittle bone disease?
Knowledge-focused Recruiting nowThis study follows up to 1,000 people with osteogenesis imperfecta, also known as brittle bone disease, a rare condition that causes bones to break easily. Researchers aim to connect each person's genetic cause with their symptoms, disease progression, and response to current tre…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Tiny coil placed inside nose could help surgeons spot hidden brain tumors
Knowledge-focused Recruiting nowThis study tests a small MRI coil placed inside the sphenoid sinus during pituitary tumor surgery. The goal is to see if it can provide clearer images of tiny tumors that standard MRI often misses. About 70 adults with pituitary tumors will take part. The coil is inserted through…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists launch deep dive into mysterious inflammatory diseases
Knowledge-focused Recruiting nowThis study aims to understand the causes and progression of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) by observing up to 2,000 participants over time. Researchers will collect medical history, blood samples, and genetic data to identify …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New imaging study aims to unlock secrets of human movement
Knowledge-focused Recruiting nowThis study uses MRI and ultrasound to watch how muscles, tendons, and bones work together when you move. Researchers hope to learn what normal and injured movement looks like, which could lead to better ways to diagnose and treat problems like knee pain. Healthy volunteers and pe…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists dig into immune signals to unlock psoriasis mystery
Knowledge-focused Recruiting nowThis study looks at 40 adults with psoriasis—some with joint pain (psoriatic arthritis) and some without—to compare immune signals in their blood and skin. Researchers want to understand why some people develop joint problems. Participants give blood and skin samples for lab anal…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New study aims to catch rare cancers early in fanconi anemia patients
Knowledge-focused Recruiting nowThis study follows people with Fanconi anemia, a rare inherited condition that raises the risk of certain cancers, especially squamous cell carcinoma. Researchers will screen 200 participants aged 12 and older every year for up to 10 years using exams, blood tests, and imaging to…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New registry tracks Real-World safety of FOP drug palovarotene
Knowledge-focused Recruiting nowThis registry study follows about 100 people with FOP, a rare disease where soft tissue turns to bone. Some participants take palovarotene (an approved treatment), while others do not. Researchers will track side effects, flare-ups, and daily function over time to see how well th…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Neck surgery showdown: which implant fuses better?
Knowledge-focused Recruiting nowThis study looks at two ways to fix a damaged disc in the neck: using a bone graft with a metal plate or a special titanium cage. Researchers will check how well the bones fuse together and track any problems. About 60 adults with degenerative disc disease will take part, and the…
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can a national biobank network end the diagnostic odyssey for rare diseases?
Knowledge-focused Recruiting nowThis study aims to create a network of biobanks across Italy that collect and store biological samples and health data from people with rare diseases and their families. The goal is to standardize how samples are collected and shared, so researchers can access high-quality materi…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a spine implant still deliver relief after 9 years?
Knowledge-focused Recruiting nowResearchers are following up with about 50 patients who received the IntraSPINE implant for lower back pain caused by degenerative disc disease. The goal is to see whether the implant still provides meaningful improvement in function and pain at least 9 years after surgery. They …
Sponsor: Cousin Biotech • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a model predict the right dose of rifampicin for bone infections?
Knowledge-focused Recruiting nowThis study looks at how the antibiotic rifampicin is processed by the body in people with staphylococcal bone and joint infections, such as prosthetic joint infections and chronic osteomyelitis. Researchers will take blood samples from 40 participants to measure drug levels and b…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Can a common mineral keep spine surgery safer?
Knowledge-focused Recruiting nowThis trial investigates whether a single dose of magnesium sulfate, given during spinal fusion surgery, changes the signals used to monitor nerve health. The study includes adults undergoing open thoracolumbar fusion with planned neuromonitoring. Researchers will measure magnesiu…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can daily habits shield RA hearts from artery stiffness?
Knowledge-focused Recruiting nowThis observational study looks at how physical activity, sedentary time, and sleep relate to early signs of heart and blood vessel disease in adults with rheumatoid arthritis. Participants will wear activity monitors for a week, answer health questionnaires, and undergo heart and…
Sponsor: São Paulo State University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can glucocorticoid treatment skew bone health tests? a study investigates
Knowledge-focused Recruiting nowThis study follows 160 people with inflammatory joint disease who are starting treatment with or without glucocorticoids, or receiving a glucocorticoid injection. Researchers will measure bone turnover markers (P1NP and CTX1) in blood samples every 4 weeks and up to 6 months afte…
Sponsor: Diakonhjemmet Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
AI decodes the mystery of persistent pain in rheumatoid arthritis
Knowledge-focused Recruiting nowThis observational study aims to understand why some people with rheumatoid arthritis (RA) continue to experience chronic pain even when their inflammation is well-controlled. Researchers will compare two groups of RA patients—those with active disease and those in remission with…
Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can men with spinal cord injury father children? a new study explores fertility options
Knowledge-focused Recruiting nowThis study aims to understand and improve fertility in men with spinal cord injury. Researchers will collect and analyze semen samples from participants to assess sperm count, motility, and other factors, and correlate these with patient characteristics. The goal is to help men w…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC